The Multitarget Action of Vitamins in the Ischemic Stroke

Luciana      Scotti; Pablo   Rayff   da Silva; Alex   France M.   Monteiro; Rodrigo   Santos  Aquino   de Araújo; Vanessa   Lima   do Nascimento; Kadja   Luana Chagas   Monteiro; Thiago   Mendonça   de Aquino; Wadja   Feitosa   dos Santos Silva; Edeildo   Ferreira   da Silva Junior; Marcus   T.   Scotti; Francisco   Jaime Bezerra   Mendonça Junior
Abstract

A stroke, also known as a cerebral hemorrhage, occurs when there is an interruption in the blood supply to a part of the brain, resulting in damage to brain cells. This issue is one of the leading causes of death in developed countries, currently killing about 5 million people annually. Individuals who survive ischemic stroke often face serious vision problems, paralysis, dementia, and other sequelae. The numerous efforts to prevent and/or treat stroke sequelae seem insufficient, which is concerning given the increasing global elderly population and the well-known association between aging and stroke risk. In this review, we aim to present and discuss the importance of vitamins in stroke prevention and/or incidence. Vitamins from diet or dietary supplements influence the body at various levels; they are a relevant factor but are reported only in isolated articles. This review reports and updates the multitarget role of vitamins involved in reducing stroke risk.
Keywords: Stroke, Vitamins, Ischemic, Risk, Prevention, Multitarget.
Graphical Abstract

[1]
Kundu, S.; Sarkar, D. Synthetic attempts towards A-tocopherol–An overview. J. Heterocycl. Chem., 2022.

[2]
Onaolapo, A.Y.; Onaolapo, O.J. Functional nutraceuticals: Past, present, and future. Handb. Nutraceuticals Nat. Prod. Biol. Med. Nutr. Prop. Appl.,  2022, 1, 15-27.

[3]
Youness, R.A.; Dawoud, A.; ElTahtawy, O.; Farag, M.A. Fat-soluble vitamins: updated review of their role and orchestration in human nutrition throughout life cycle with sex differences. Nutr. Metab. (Lond.),  2022, 19(1), 60.
 [http://dx.doi.org/10.1186/s12986-022-00696-y] [PMID: 36064551]

[4]
Limketkai, B.N.; Matarese, L.E.; Mullin, G.E. Vitamins and minerals. In: Yamada's Textbook of Gastroenterology; , 2022; pp. 426-456.
 [http://dx.doi.org/10.1002/9781119600206.ch22.]

[5]
Kong, J.; Chu, R.; Wang, Y. Neuroprotective Treatments for Ischemic Stroke: Opportunities for Nanotechnology. Adv. Funct. Mater.,  2022, 32(52), 2209405.
 [http://dx.doi.org/10.1002/adfm.202209405]

[6]
Huber, C.C.; Wang, X.; Wang, H. Impact of Cardiovascular Diseases on Ischemic Stroke Outcomes. J. Integr. Neurosci.,  2022, 21(5), 138.
 [http://dx.doi.org/10.31083/j.jin2105138] [PMID: 36137958]

[7]
Caplan, L.R.; Simon, R.P.; Hassani, S. Cerebrovascular Disease—Stroke. In: Neurobiology of Brain Disorders; Academic Press, 2023; pp. 457-476.
 [http://dx.doi.org/10.1016/B978-0-323-85654-6.00044-7]

[8]
Omaye, ST.; Schaus, EE.; Kutnink, MA.; Hawkes, WC. Measurement of vitamin C in blood components by high-performance liquid chromatography. Implication in assessing vitamin C status. Ann N Y Acad Sci,  1987, 498, 389-401.
 [http://dx.doi.org/10.1111/j.1749-6632.1987.tb23776.x]

[9]
Cerullo, G.; Negro, M.; Parimbelli, M.; Pecoraro, M.; Perna, S.; Liguori, G.; Rondanelli, M.; Cena, H.; D’Antona, G. The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19. Front. Immunol.,  2020, 11, 574029.
 [http://dx.doi.org/10.3389/fimmu.2020.574029] [PMID: 33193359]

[10]
Chen, Q.; Vissers, M.C.M. Vitamin C: New Biochemical and Functional Insights; CRC Press, 2020, 1, . 
 [http://dx.doi.org/10.1201/9780429442025]

[11]
Van Gorkom, G.; Klein Wolterink, R.; Van Elssen, C.; Wieten, L.; Germeraad, W.; Bos, G. Influence of Vitamin C on Lymphocytes: An Overview. Antioxidants,  2018, 7(3), 41.
 [http://dx.doi.org/10.3390/antiox7030041] [PMID: 29534432]

[12]
Liugan, M.; Carr, A.C. Vitamin C and Neutrophil Function: Findings from Randomized Controlled Trials. Nutrients,  2019, 11(9), 2102.
 [http://dx.doi.org/10.3390/nu11092102] [PMID: 31487891]

[13]
Min, Y.N.; Niu, Z.Y.; Sun, T.T.; Wang, Z.P.; Jiao, P.X.; Zi, B.B.; Chen, P.P.; Tian, D.L.; Liu, F.Z.; Vitamin, E.; Vitamin, C. Vitamin E and vitamin C supplementation improves antioxidant status and immune function in oxidative-stressed breeder roosters by up-regulating expression of GSH-Px gene. Poult. Sci.,  2018, 97(4), 1238-1244.
 [http://dx.doi.org/10.3382/ps/pex417] [PMID: 29452404]

[14]
Chen, G.; Chang, T.M.S. Dual antioxidant and pro-oxidation effects of ascorbic acid on bovine hemoglobin. In: Nanobiotherapeutic Based Blood Substitutes; World Scientific, 2022; pp. 571-595.
 [http://dx.doi.org/10.1142/9789811228698_0023]

[15]
Chang, C.Y.; Chen, J.Y.; Wu, M.H.; Hu, M.L. Therapeutic treatment with vitamin C reduces focal cerebral ischemia-induced brain infarction in rats by attenuating disruptions of blood brain barrier and cerebral neuronal apoptosis. Free Radic. Biol. Med.,  2020, 155, 29-36.
 [http://dx.doi.org/10.1016/j.freeradbiomed.2020.05.015] [PMID: 32450129]

[16]
O’Neill, M.J.; Clemens, J.A. Rodent models of focal cerebral ischemia. Curr. Protoc. Neurosci.,  2001, Chapter 9(1), 6-9.
 [PMID: 18428554]

[17]
Orellana-Urzúa, S.; Rojas, I.; Líbano, L.; Rodrigo, R. Pathophysiology of Ischemic Stroke: Role of Oxidative Stress. Curr. Pharm. Des.,  2020, 26(34), 4246-4260.
 [http://dx.doi.org/10.2174/1381612826666200708133912] [PMID: 32640953]

[18]
Zhao, X.; He, Y.; Zhang, Y.; Wan, H.; Wan, H.; Yang, J. Inhibition of Oxidative Stress: An Important Molecular Mechanism of Chinese Herbal Medicine (Astragalus membranaceus, Carthamus tinctorius L., Radix Salvia Miltiorrhizae, etc.) in the Treatment of Ischemic Stroke by Regulating the Antioxidant System. Oxid. Med. Cell. Longev.,  2022, 2022, 1-10.
 [http://dx.doi.org/10.1155/2022/1425369] [PMID: 35651725]

[19]
Hill, A.; Wendt, S.; Benstoem, C.; Neubauer, C.; Meybohm, P.; Langlois, P.; Adhikari, N.K.J.; Heyland, D.K.; Stoppe, C. Vitamin C to Improve Organ Dysfunction in Cardiac Surgery Patients—Review and Pragmatic Approach. Nutrients,  2018, 10(8), 974.
 [http://dx.doi.org/10.3390/nu10080974] [PMID: 30060468]

[20]
Hu, D.; Serrano, F.; Oury, T.D.; Klann, E. Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase. J. Neurosci.,  2006, 26(15), 3933-3941.
 [http://dx.doi.org/10.1523/JNEUROSCI.5566-05.2006] [PMID: 16611809]

[21]
Jelinek, M.; Jurajda, M.; Duris, K. Oxidative Stress in the Brain: Basic Concepts and Treatment Strategies in Stroke. Antioxidants,  2021, 10(12), 1886.
 [http://dx.doi.org/10.3390/antiox10121886] [PMID: 34942989]

[22]
Jaganjac, M.; Milkovic, L.; Zarkovic, N.; Zarkovic, K. Oxidative stress and regeneration. Free Radic. Biol. Med.,  2022, 181, 154-165.
 [http://dx.doi.org/10.1016/j.freeradbiomed.2022.02.004] [PMID: 35149216]

[23]
Komsiiska, D. Oxidative stress and stroke: a review of upstream and downstream antioxidant therapeutic options. Comp. Clin. Pathol.,  2019, 28(4), 915-926.
 [http://dx.doi.org/10.1007/s00580-019-02940-z]

[24]
Jin, T.; Leng, B. Cynaropicrin Averts the Oxidative Stress and Neuroinflammation in Ischemic/Reperfusion Injury Through the Modulation of NF-KB. Appl. Biochem. Biotechnol.,  2022, 1-15.
 [PMID: 35838888]

[25]
Venø, S.K.; Bork, C.S.; Jakobsen, M.U.; Lundbye-Christensen, S.; McLennan, P.L.; Bach, F.W.; Overvad, K.; Schmidt, E.B. Marine n-3 Polyunsaturated Fatty Acids and the Risk of Ischemic Stroke. Stroke,  2019, 50(2), 274-282.
 [http://dx.doi.org/10.1161/STROKEAHA.118.023384] [PMID: 30602356]

[26]
Jurcau, A.; Ardelean, A.I. Oxidative Stress in Ischemia/Reperfusion Injuries following Acute Ischemic Stroke. Biomedicines,  2022, 10(3), 574.
 [http://dx.doi.org/10.3390/biomedicines10030574] [PMID: 35327376]

[27]
Miao, R.; Li, J.; Meng, C.; Li, Y.; Tang, H.; Wang, J.; Deng, P.; Lu, Y. Diet-derived circulating antioxidants and risk of stroke: A Mendelian randomization study. Oxid Med Cell Longev,  2022, 2022, 6457318.
 [http://dx.doi.org/10.1155/2022/6457318]

[28]
Nagele, P. The importance of definitive trials: The VIXIE trial. Anesthesiology,  2022, 136(3), 403-404.
 [http://dx.doi.org/10.1097/ALN.0000000000004144.]

[29]
Chen, X.; Li, H.; Zhang, B.; Deng, Z. The synergistic and antagonistic antioxidant interactions of dietary phytochemical combinations. Crit. Rev. Food Sci. Nutr.,  2022, 62(20), 5658-5677.
 [http://dx.doi.org/10.1080/10408398.2021.1888693] [PMID: 33612011]

[30]
Doseděl, M.; Jirkovský, E.; Macáková, K.; Krčmová, L.; Javorská, L.; Pourová, J.; Mercolini, L.; Remião, F.; Nováková, L.; Mladěnka, P. Vitamin C—Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination. Nutrients,  2021, 13(2), 615.
 [http://dx.doi.org/10.3390/nu13020615] [PMID: 33668681]

[31]
Icer, M.A.; Arslan, N.; Gezmen-Karadag, M. Effects of vitamin E on neurodegenerative diseases: an update. Acta Neurobiol. Exp. (Warsz.),  2021, 81(1), 21-33.
 [http://dx.doi.org/10.21307/ane-2021-003] [PMID: 33949169]

[32]
Manosso, L.M.; Camargo, A.; Dafre, A.L.; Rodrigues, A.L.S. Vitamin E for the management of major depressive disorder: possible role of the anti-inflammatory and antioxidant systems. Nutr. Neurosci.,  2022, 25(6), 1310-1324.
 [http://dx.doi.org/10.1080/1028415X.2020.1853417] [PMID: 33314993]

[33]
Rychter, A.M.; Hryhorowicz, S.; Słomski, R.; Dobrowolska, A.; Krela-Kaźmierczak, I. Antioxidant effects of vitamin E and risk of cardiovascular disease in women with obesity – A narrative review. Clin. Nutr.,  2022, 41(7), 1557-1565.
 [http://dx.doi.org/10.1016/j.clnu.2022.04.032] [PMID: 35667272]

[34]
Jiang, Q. Metabolism of natural forms of vitamin E and biological actions of vitamin E metabolites. Free Radic. Biol. Med.,  2022, 179, 375-387.
 [http://dx.doi.org/10.1016/j.freeradbiomed.2021.11.012] [PMID: 34785321]

[35]
Simion, A.; Jurcau, A. The Role of Antioxidant Treatment in Acute Ischemic Stroke: Past, Present and Future. Neurology - Research & Surgery,  2019, 2, 1-7.
 [http://dx.doi.org/10.33425/2641-4333.1017]

[36]
Loh, H.C.; Lim, R.; Lee, K.W.; Ooi, C.Y.; Chuan, D.R.; Looi, I.; Kah Hay, Y.; Abdul Karim Khan, N. Effects of vitamin E on stroke: a systematic review with meta-analysis and trial sequential analysis. Stroke Vasc. Neurol.,  2021, 6(1), 109-120.
 [http://dx.doi.org/10.1136/svn-2020-000519] [PMID: 33109618]

[37]
Violi, F.; Nocella, C.; Loffredo, L.; Carnevale, R.; Pignatelli, P. Interventional study with vitamin E in cardiovascular disease and meta-analysis. Free Radic. Biol. Med.,  2022, 178, 26-41.
 [http://dx.doi.org/10.1016/j.freeradbiomed.2021.11.027] [PMID: 34838937]

[38]
Aranda-Rivera, A.K.; Cruz-Gregorio, A.; Arancibia-Hernández, Y.L.; Hernández-Cruz, E.Y.; Pedraza-Chaverri, J. RONS and Oxidative Stress: An Overview of Basic Concepts. Oxygen,  2022, 2(4), 437-478.
 [http://dx.doi.org/10.3390/oxygen2040030]

[39]
de Almeida, A. J. P. O.; de Oliveira, J. C. P. L.; da Silva Pontes, L. V.; de Souza Júnior, J. F.; Gonçalves, T. A. F.; Dantas, S. H.; de Almeida Feitosa, M. S.; Silva, A. O.; de Medeiros, I. A. ROS: Basic concepts, sources, cellular signaling, and its implications in aging pathways. Oxid Med Cell Longev,  2022, 2022, 1225578.
 [http://dx.doi.org/10.1155/2022/1225578.]

[40]
Newman, M.; Connery, H.; Boyd, J. Opioids and Vitamin C: Known Interactions and Potential for Redox-Signaling Crosstalk. Antioxidants,  2022, 11(7), 1267.
 [http://dx.doi.org/10.3390/antiox11071267] [PMID: 35883757]

[41]
Rasmussen, K.; Møller, J. Total homocysteine measurement in clinical practice. Ann. Clin. Biochem.,  2000, 37(5), 627-648.
 [http://dx.doi.org/10.1258/0004563001899915] [PMID: 11026516]

[42]
Kelly, P.J.; Rosand, J.; Kistler, J.P.; Shih, V.E.; Silveira, S.; Plomaritoglou, A.; Furie, K.L. Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke. Neurology,  2002, 59(4), 529-536.
 [http://dx.doi.org/10.1212/WNL.59.4.529] [PMID: 12196644]

[43]
Moriyama, Y.; Okamura, T.; Kajinami, K.; Iso, H.; Inazu, A.; Kawashiri, M.; Mizuno, M.; Takeda, Y.; Sakamoto, Y.; Kimura, H.; Suzuki, H.; Mabuchi, H. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis,  2002, 164(2), 321-328.
 [http://dx.doi.org/10.1016/S0021-9150(02)00105-3] [PMID: 12204804]

[44]
Eikelboom, J.W.; Lonn, E.; Genest, J., Jr; Hankey, G.; Yusuf, S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med.,  1999, 131(5), 363-375.
 [http://dx.doi.org/10.7326/0003-4819-131-5-199909070-00008] [PMID: 10475890]

[45]
Herrmann, W. The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin. Chem. Lab. Med.,  2001, 39(8), 666-674.
 [http://dx.doi.org/10.1515/CCLM.2001.110] [PMID: 11592431]

[46]
Durand, P.; Prost, M.; Loreau, N.; Lussier-Cacan, S.; Blache, D. Impaired homocysteine metabolism and atherothrombotic disease. Lab. Invest.,  2001, 81(5), 645-672.
 [http://dx.doi.org/10.1038/labinvest.3780275] [PMID: 11351038]

[47]
Topal, G.; Brunet, A.; Millanvoye, E.; Boucher, J.L.; Rendu, F.; Devynck, M.A.; David-Dufilho, M. Homocysteine induces oxidative stress by uncoupling of no synthase activity through reduction of tetrahydrobiopterin. Free Radic. Biol. Med.,  2004, 36(12), 1532-1541.
 [http://dx.doi.org/10.1016/j.freeradbiomed.2004.03.019] [PMID: 15182855]

[48]
Lynch, S.M.; Frei, B. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochim. Biophys. Acta Lipids Lipid Metab.,  1997, 1345(2), 215-221.
 [http://dx.doi.org/10.1016/S0005-2760(96)00182-8] [PMID: 9106501]

[49]
Poddar, R.; Sivasubramanian, N.; DiBello, P.M.; Robinson, K.; Jacobsen, D.W. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation,  2001, 103(22), 2717-2723.
 [http://dx.doi.org/10.1161/01.CIR.103.22.2717] [PMID: 11390343]

[50]
Refsum, H.; Ueland, P.M.; Nygård, O.; Vollset, S.E. Homocysteine and cardiovascular disease. Annu. Rev. Med.,  1998, 49(1), 31-62.
 [http://dx.doi.org/10.1146/annurev.med.49.1.31] [PMID: 9509248]

[51]
Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA,  2002, 288(16), 2015-2022.
 [http://dx.doi.org/10.1001/jama.288.16.2015] [PMID: 12387654]

[52]
Fallon, U.B.; Virtamo, J.; Young, I.; McMaster, D.; Ben-Shlomo, Y.; Wood, N.; Whitehead, A.S.; Smith, G.D. Homocysteine and cerebral infarction in finnish male smokers. Stroke,  2003, 34(6), 1359-1363.
 [http://dx.doi.org/10.1161/01.STR.0000074035.64365.2D] [PMID: 12750538]

[53]
Iso, H.; Moriyama, Y.; Sato, S.; Kitamura, A.; Tanigawa, T.; Yamagishi, K.; Imano, H.; Ohira, T.; Okamura, T.; Naito, Y.; Shimamoto, T. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation,  2004, 109(22), 2766-2772.
 [http://dx.doi.org/10.1161/01.CIR.0000131942.77635.2D] [PMID: 15159287]

[54]
Wald, D.S.; Law, M.; Morris, J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ,  2002, 325(7374), 1202-1206.
 [http://dx.doi.org/10.1136/bmj.325.7374.1202] [PMID: 12446535]

[55]
Wang, W.W.; Wang, X.S.; Zhang, Z.R.; He, J.C.; Xie, C.L. A Meta-Analysis of Folic Acid in Combination with Anti-Hypertension Drugs in Patients with Hypertension and Hyperhomocysteinemia. Front. Pharmacol.,  2017, 8, 585.
 [http://dx.doi.org/10.3389/fphar.2017.00585] [PMID: 28912716]

[56]
Saposnik, G.; Ray, J.G.; Sheridan, P.; McQueen, M.; Lonn, E. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke,  2009, 40(4), 1365-1372.
 [http://dx.doi.org/10.1161/STROKEAHA.108.529503] [PMID: 19228852]

[57]
Biswas, A.; Ranjan, R.; Meena, A.; Akhter, M.S.; Yadav, B.K.; Munisamy, M.; Subbiah, V.; Behari, M.; Saxena, R. Homocystine levels, polymorphisms and the risk of ischemic stroke in young Asian Indians. J. Stroke Cerebrovasc. Dis.,  2009, 18(2), 103-110.
 [http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2008.09.014] [PMID: 19251185]

[58]
Selhub, J.; Jacques, P.F.; Bostom, A.G.; D’Agostino, R.B.; Wilson, P.W.F.; Belanger, A.J.; O’Leary, D.H.; Wolf, P.A.; Schaefer, E.J.; Rosenberg, I.H. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N. Engl. J. Med.,  1995, 332(5), 286-291.
 [http://dx.doi.org/10.1056/NEJM199502023320502] [PMID: 7816063]

[59]
Hackam, D.; Peterson, J.C.; Spence, J.D. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L. Am. J. Hypertens.,  2000, 13(1), 105-110.
 [http://dx.doi.org/10.1016/S0895-7061(99)00180-6] [PMID: 10678280]

[60]
Jacques, P.F.; Selhub, J.; Bostom, A.G.; Wilson, P.W.F.; Rosenberg, I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N. Engl. J. Med.,  1999, 340(19), 1449-1454.
 [http://dx.doi.org/10.1056/NEJM199905133401901] [PMID: 10320382]

[61]
Merrill, A.H.; Horiike, K.; McCormick, D.B. Evidence for the regulation of pyridoxal 5′-phosphate formation in liver by pyridoxamine (pyridoxine) 5′-phosphate oxidase. Biochem. Biophys. Res. Commun.,  1978, 83(3), 984-990.
 [http://dx.doi.org/10.1016/0006-291X(78)91492-4] [PMID: 708447]

[62]
Barlowe, C.K.; Appling, D.R. In vitro evidence for the involvement of mitochondrial folate metabolism in the supply of cytoplasmic one-carbon units. Biofactors,  1988, 1(2), 171-176.
 [PMID: 2475123]

[63]
Oh, K-J.; Churchich, J.E. Binding of pyridoxal 5-phosphate to cystathionase. J. Biol. Chem.,  1973, 248(21), 7370-7375.
 [http://dx.doi.org/10.1016/S0021-9258(19)43298-5] [PMID: 4795694]

[64]
Taoka, S.; West, M.; Banerjee, R. Characterization of the heme and pyridoxal phosphate cofactors of human cystathionine β-synthase reveals nonequivalent active sites. Biochemistry,  1999, 38(9), 2738-2744.
 [http://dx.doi.org/10.1021/bi9826052] [PMID: 10052944]

[65]
Jones, C.W., III; Priest, D.G. Interaction of pyridoxal 5-phosphate with apo-serine hydroxymethyltransferase. Biochimica et Biophysica Acta (BBA) - Enzymology,  1978, 526(2), 369-374.
 [http://dx.doi.org/10.1016/0005-2744(78)90128-6] [PMID: 31178]

[66]
Martinez, M.; Cuskelly, G.J.; Williamson, J.; Toth, J.P.; Gregory, J.F., III Vitamin B-6 deficiency in rats reduces hepatic serine hydroxymethyltransferase and cystathionine β-synthase activities and rates of in vivo protein turnover, homocysteine remethylation and transsulfuration. J. Nutr.,  2000, 130(5), 1115-1123.
 [http://dx.doi.org/10.1093/jn/130.5.1115] [PMID: 10801907]

[67]
Perry, C.; Yu, S.; Chen, J.; Matharu, K.S.; Stover, P.J. Effect of vitamin B6 availability on serine hydroxymethyltransferase in MCF-7 cells. Arch. Biochem. Biophys.,  2007, 462(1), 21-27.
 [http://dx.doi.org/10.1016/j.abb.2007.04.005] [PMID: 17482557]

[68]
Chen, H.; Xiong, L. Pyridoxine is required for post-embryonic root development and tolerance to osmotic and oxidative stresses. Plant J.,  2005, 44(3), 396-408.
 [http://dx.doi.org/10.1111/j.1365-313X.2005.02538.x] [PMID: 16236150]

[69]
Chumnantana, R.; Yokochi, N.; Yagi, T. Vitamin B6 compounds prevent the death of yeast cells due to menadione, a reactive oxygen generator. Biochim. Biophys. Acta, Gen. Subj.,  2005, 1722(1), 84-91.
 [http://dx.doi.org/10.1016/j.bbagen.2004.11.013] [PMID: 15716132]

[70]
Endo, N.; Nishiyama, K.; Okabe, M.; Matsumoto, M.; Kanouchi, H.; Oka, T. Vitamin B6 suppresses apoptosis of NM-1 bovine endothelial cells induced by homocysteine and copper. Biochim. Biophys. Acta, Gen. Subj.,  2007, 1770(4), 571-577.
 [http://dx.doi.org/10.1016/j.bbagen.2006.11.009] [PMID: 17208380]

[71]
Fukui, K.O.; Kubota, M.; Terashima, H.; Ishiguro, A.; Kashii, H. Early administration of vitamins B1 and B6 and l-carnitine prevents a second attack of acute encephalopathy with biphasic seizures and late reduced diffusion: A case control study. Brain Dev.,  2019, 41(7), 618-624.
 [http://dx.doi.org/10.1016/j.braindev.2019.02.015] [PMID: 30862409]

[72]
Wilcken, D.E.; Wilcken, B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J. Clin. Invest.,  1976, 57(4), 1079-1082.
 [http://dx.doi.org/10.1172/JCI108350] [PMID: 947949]

[73]
Pancharuniti, N.; Lewis, C.A.; Sauberlich, H.E.; Perkins, L.L.; Go, R.C.; Alvarez, J.O.; Macaluso, M.; Acton, R.T.; Copeland, R.B.; Cousins, A.L.; Gore, T.B.; Cornwell, P.E.; Roseman, J.M. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am. J. Clin. Nutr.,  1994, 59(4), 940-948.
 [http://dx.doi.org/10.1093/ajcn/59.4.940] [PMID: 8147342]

[74]
Robinson, K.; Mayer, E.L.; Miller, D.P.; Green, R.; van Lente, F.; Gupta, A.; Kottke-Marchant, K.; Savon, S.R.; Selhub, J.; Nissen, S.E.; Kutner, M.; Topol, E.J.; Jacobsen, D.W. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation,  1995, 92(10), 2825-2830.
 [http://dx.doi.org/10.1161/01.CIR.92.10.2825] [PMID: 7586248]

[75]
Graham, I.M.; Daly, L.E.; Refsum, H.M.; Robinson, K.; Brattström, L.E.; Ueland, P.M.; Palma-Reis, R.J.; Boers, G.H.; Sheahan, R.G.; Israelsson, B.; Uiterwaal, C.S.; Meleady, R.; McMaster, D.; Verhoef, P.; Witteman, J.; Rubba, P.; Bellet, H.; Wautrecht, J.C.; de Valk, H.W.; Sales Lúis, A.C.; Parrot-Rouland, F.M.; Tan, K.S.; Higgins, I.; Garcon, D.; Andria, G. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA,  1997, 277(22), 1775-1781.
 [http://dx.doi.org/10.1001/jama.1997.03540460039030] [PMID: 9178790]

[76]
Boushey, C.J.; Beresford, S.A.; Omenn, G.S.; Motulsky, A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA,  1995, 274(13), 1049-1057.
 [http://dx.doi.org/10.1001/jama.1995.03530130055028] [PMID: 7563456]

[77]
Gungor, L.; Polat, M.; Ozberk, M.B.; Avci, B.; Abur, U. Which Ischemic Stroke Subtype Is Associated with Hyperhomocysteinemia? J. Stroke Cerebrovasc. Dis.,  2018, 27(7), 1921-1929.
 [http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2018.02.033] [PMID: 29661647]

[78]
Boers, G.H.J.; Smals, A.G.H.; Trijbels, F.J.M.; Fowler, B.; Bakkeren, J.A.J.M.; Schoonderwaldt, H.C.; Kleijer, W.J.; Kloppenborg, P.W.C. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med.,  1985, 313(12), 709-715.
 [http://dx.doi.org/10.1056/NEJM198509193131201] [PMID: 4033695]

[79]
Brattström, L.; Israelsson, B.; Norrving, B.; Bergqvist, D.; Thörne, J.; Hultberg, B.; Hamfelt, A. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease Effects of pyridoxine and folic acid treatment. Atherosclerosis,  1990, 81(1), 51-60.
 [http://dx.doi.org/10.1016/0021-9150(90)90058-Q] [PMID: 2407253]

[80]
Clarke, R.; Daly, L.; Robinson, K.; Naughten, E.; Cahalane, S.; Fowler, B.; Graham, I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med.,  1991, 324(17), 1149-1155.
 [http://dx.doi.org/10.1056/NEJM199104253241701] [PMID: 2011158]

[81]
Malinow, M.R.; Kang, S.S.; Taylor, L.M.; Wong, P.W.; Coull, B.; Inahara, T.; Mukerjee, D.; Sexton, G.; Upson, B. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation,  1989, 79(6), 1180-1188.
 [http://dx.doi.org/10.1161/01.CIR.79.6.1180] [PMID: 2785871]

[82]
Taylor, L.M., Jr; DeFrang, R.D.; Harris, E.J., Jr; Porter, J.M. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J. Vasc. Surg.,  1991, 13(1), 128-136.
 [http://dx.doi.org/10.1016/0741-5214(91)90020-U] [PMID: 1987384]

[83]
Arnesen, E.; Refsum, H.; Bønaa, K.H.; Ueland, P.M.; Førde, O.H.; Nordrehaug, J. Serum total homocysteine and coronary heart disease. Int. J. Epidemiol.,  1995, 24(4), 704-709.
 [http://dx.doi.org/10.1093/ije/24.4.704] [PMID: 8550266]

[84]
Brattström, L.; Lindgren, A.; Israelsson, B.; Malinow, M.R.; Norrving, B.; Upson, B.; Hamfelt, A. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur. J. Clin. Invest.,  1992, 22(3), 214-221.
 [http://dx.doi.org/10.1111/j.1365-2362.1992.tb01829.x] [PMID: 1582447]

[85]
Dudman, N.P.; Wilcken, D.E.; Wang, J.; Lynch, J.F.; Macey, D.; Lundberg, P. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler. Thromb.,  1993, 13(9), 1253-1260.
 [http://dx.doi.org/10.1161/01.ATV.13.9.1253] [PMID: 8364009]

[86]
Stabler, S.P.; Marcell, P.D.; Podell, E.R.; Allen, R.H.; Savage, D.G.; Lindenbaum, J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J. Clin. Invest.,  1988, 81(2), 466-474.
 [http://dx.doi.org/10.1172/JCI113343] [PMID: 3339129]

[87]
Brattström, L.; Israelsson, B.; Lindgärde, F.; Hultberg, B. Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiency. Metabolism,  1988, 37(2), 175-178.
 [http://dx.doi.org/10.1016/S0026-0495(98)90014-2] [PMID: 3340005]

[88]
Selhub, J.; Jacques, P.F.; Wilson, P.W.; Rush, D.; Rosenberg, I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA,  1993, 270(22), 2693-2698.
 [http://dx.doi.org/10.1001/jama.1993.03510220049033] [PMID: 8133587]

[89]
Naess, H.; Nyland, H.; Idicula, T.; Waje-Andreassen, U. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients. J. Stroke Cerebrovasc. Dis.,  2013, 22(8), e435-e440.
 [http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2013.04.031] [PMID: 23735372]

[90]
Shi, Z.; Guan, Y.; Huo, Y.R.; Liu, S.; Zhang, M.; Lu, H.; Yue, W.; Wang, J.; Ji, Y. Elevated Total Homocysteine Levels in Acute Ischemic Stroke Are Associated With Long-Term Mortality. Stroke,  2015, 46(9), 2419-2425.
 [http://dx.doi.org/10.1161/STROKEAHA.115.009136] [PMID: 26199315]

[91]
Zhong, C.; Lv, L.; Liu, C.; Zhao, L.; Zhou, M.; Sun, W.; Xu, T.; Tong, W. High homocysteine and blood pressure related to poor outcome of acute ischemia stroke in Chinese population. PLoS One,  2014, 9(9), e107498.
 [http://dx.doi.org/10.1371/journal.pone.0107498] [PMID: 25265507]

[92]
Kwon, H.M.; Lee, Y.S.; Bae, H.J.; Kang, D.W. Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke. Stroke,  2014, 45(3), 871-873.
 [http://dx.doi.org/10.1161/STROKEAHA.113.004099] [PMID: 24448992]

[93]
Ye, Z.; Zhang, Z.; Zhang, H.; Hao, Y.; Zhang, J.; Liu, W.; Xu, G.; Liu, X. Prognostic Value of C-Reactive Protein and Homocysteine in Large-Artery Atherosclerotic Stroke: a Prospective Observational Study. J. Stroke Cerebrovasc. Dis.,  2017, 26(3), 618-626.
 [http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2016.11.016] [PMID: 27979431]

[94]
Bos, M.J.; van Goor, M.L.P.J.; Koudstaal, P.J.; Dippel, D.W.J. Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA. J. Neurol.,  2005, 252(3), 332-337.
 [http://dx.doi.org/10.1007/s00415-005-0647-9] [PMID: 15739046]

[95]
Del Ser, T.; Barba, R.; Herranz, A.S.; Seijas, V.; López- Manglano, C.; Domingo, J.; Pondal, M. Hyperhomocyst(e)inemia is a risk factor of secondary vascular events in stroke patients. Cerebrovasc. Dis.,  2001, 12(2), 91-98.
 [http://dx.doi.org/10.1159/000047687] [PMID: 11490102]

[96]
Li, Z.; Sun, L.; Zhang, H.; Liao, Y.; Wang, D.; Zhao, B.; Zhu, Z.; Zhao, J.; Ma, A.; Han, Y.; Wang, Y.; Shi, Y.; Ye, J.; Hui, R. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke,  2003, 34(9), 2085-2090.
 [http://dx.doi.org/10.1161/01.STR.0000086753.00555.0D] [PMID: 12907815]

[97]
Hofmann, M.A.; Lalla, E.; Lu, Y.; Gleason, M.R.; Wolf, B.M.; Tanji, N.; Ferran, L.J., Jr; Kohl, B.; Rao, V.; Kisiel, W.; Stern, D.M.; Schmidt, A.M. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest.,  2001, 107(6), 675-683.
 [http://dx.doi.org/10.1172/JCI10588] [PMID: 11254667]

[98]
Aikawa, M.; Rabkin, E.; Okada, Y.; Voglic, S.J.; Clinton, S.K.; Brinckerhoff, C.E.; Sukhova, G.K.; Libby, P. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation,  1998, 97(24), 2433-2444.
 [http://dx.doi.org/10.1161/01.CIR.97.24.2433] [PMID: 9641696]

[99]
Mach, F.; Schönbeck, U.; Bonnefoy, J.Y.; Pober, J.S.; Libby, P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation,  1997, 96(2), 396-399.
 [http://dx.doi.org/10.1161/01.CIR.96.2.396] [PMID: 9244201]

[100]
Martí-Carvajal, A.J.; Solà, I.; Lathyris, D.; Salanti, G. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev,  2009, (4), CD006612.
 [http://dx.doi.org/10.1002/14651858.CD006612.pub2]

[101]
Park, J.H.; Saposnik, G.; Ovbiagele, B.; Markovic, D.; Towfighi, A. Effect of B-vitamins on stroke risk among individuals with vascular disease who are not on antiplatelets: A meta-analysis. Int. J. Stroke,  2016, 11(2), 206-211.
 [http://dx.doi.org/10.1177/1747493015616512] [PMID: 26783312]

[102]
Ji, Y.; Tan, S.; Xu, Y.; Chandra, A.; Shi, C.; Song, B.; Qin, J.; Gao, Y.; Vitamin, B. Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease. Neurology,  2013, 81(15), 1298-1307.
 [http://dx.doi.org/10.1212/WNL.0b013e3182a823cc] [PMID: 24049135]

[103]
Apeland, T.; Frøyland, E.S.; Kristensen, O.; Strandjord, R.E.; Mansoor, M.A. Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: Improvement by B-vitamins. Epilepsy Res.,  2008, 82(1), 1-6.
 [http://dx.doi.org/10.1016/j.eplepsyres.2008.06.003] [PMID: 18644700]

[104]
Sato, K.; Morofuji, Y.; Horie, N.; Izumo, T.; Anda, T.; Matsuo, T. Hyperhomocysteinemia Causes Severe Intraoperative Thrombotic Tendency in Superficial Temporal Artery-middle Cerebral Artery Bypass. J. Stroke Cerebrovasc. Dis.,  2020, 29(5), 104633.
 [http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2019.104633] [PMID: 32122776]

[105]
Endo, N.; Nishiyama, K.; Otsuka, A.; Kanouchi, H.; Taga, M.; Oka, T. Antioxidant activity of vitamin B 6 delays homocysteine-induced atherosclerosis in rats. Br. J. Nutr.,  2006, 95(6), 1088-1093.
 [http://dx.doi.org/10.1079/BJN20061764] [PMID: 16768830]

[106]
Rinehart, J.F.; Greenberg, L.D. Arteriosclerotic lesions in pyridoxine-deficient monkeys. Am. J. Pathol.,  1949, 25(3), 481-491.
 [PMID: 18127137]

[107]
Chasan-Taber, L.; Selhub, J.; Rosenberg, I.H.; Malinow, M.R.; Terry, P.; Tishler, P.V.; Willett, W.; Hennekens, C.H.; Stampfer, M.J. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J. Am. Coll. Nutr.,  1996, 15(2), 136-143.
 [http://dx.doi.org/10.1080/07315724.1996.10718578] [PMID: 8778142]

[108]
Folsom, A.R.; Nieto, F.J.; McGovern, P.G.; Tsai, M.Y.; Malinow, M.R.; Eckfeldt, J.H.; Hess, D.L.; Davis, C.E. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation,  1998, 98(3), 204-210.
 [http://dx.doi.org/10.1161/01.CIR.98.3.204] [PMID: 9697819]

[109]
Robinson, K.; Arheart, K.; Refsum, H.; Brattström, L.; Boers, G.; Ueland, P.; Rubba, P.; Palma-Reis, R.; Meleady, R.; Daly, L.; Witteman, J.; Graham, I. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation,  1998, 97(5), 437-443.
 [http://dx.doi.org/10.1161/01.CIR.97.5.437] [PMID: 9490237]

[110]
Tietz, N.W. Clinical Guide to Laboratory Tests; Tietz, N.W., Ed.; W.B. Saunders: Philadelphia, 1995. 

[111]
Leklem, J.E. Vitamin B6. In: Modern Nutrition in Health and Disease; Shils, M.; Olson, J.A.; Shike, M.; Ross, A.C., Eds.; Williams & Wilkins: Baltimore, 1994; pp. 383-394.

[112]
Kok, F.J.; Schrijver, J.; Hofman, A.; Witteman, J.C.M.; Kruyssen, D.A.C.M.; Remme, W.J.; Valkenburg, H.A. Low vitamin B6 in patients with acute myocardial infarction. Am. J. Cardiol.,  1989, 63(9), 513-516.
 [http://dx.doi.org/10.1016/0002-9149(89)90890-4] [PMID: 2919556]

[113]
Vermaak, W.J. Barnard, H.; Potgieter, G.; du T. Theron, H. Vitamin B6 and Coronary Artery Disease. Atherosclerosis,  1987, 63(2–3), 235-238.
 [http://dx.doi.org/10.1016/0021-9150(87)90126-2] [PMID: 3827984]

[114]
Vermaak, W.J.H.; Barnard, H.C.; Dalen, E.M.S.P.; Potgieter, G.M.; Jaarsveld, H.; Myburgh, S.J.S. Compartmentalization of pyridoxal-5′-phosphate during the acute phase of myocardial infarction. Klin. Wochenschr.,  1988, 66(10), 428-433.
 [http://dx.doi.org/10.1007/BF01745511] [PMID: 3398428]

[115]
Brattström, L.E.; Israelsson, B.; Jeppsson, J.O.; Hultberg, B.L. Folic acid—an innocuous means to reduce plasma homocysteine. Scand. J. Clin. Lab. Invest.,  1988, 48(3), 215-221.
 [http://dx.doi.org/10.3109/00365518809167487] [PMID: 3375778]

[116]
Landgren, F.; Israelsson, B.; Lindgren, A.; Hultberg, B.; Andersson, A.; Brattström, L. Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J. Intern. Med.,  1995, 237(4), 381-388.
 [http://dx.doi.org/10.1111/j.1365-2796.1995.tb01190.x] [PMID: 7714461]

[117]
Naurath, H.J.; Joosten, E.; Riezler, R.; Stabler, S.; Allen, R.H.; Lindenbaum, J. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet,  1995, 346(8967), 85-89.
 [http://dx.doi.org/10.1016/S0140-6736(95)92113-3] [PMID: 7603218]

[118]
Ubbink, J.B.; Vermaak, W.J.; van der Merwe, A.; Becker, P.J. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am. J. Clin. Nutr.,  1993, 57(1), 47-53.
 [http://dx.doi.org/10.1093/ajcn/57.1.47] [PMID: 8416664]

[119]
He, K.; Merchant, A.; Rimm, E.B.; Rosner, B.A.; Stampfer, M.J.; Willett, W.C.; Ascherio, A. Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke,  2004, 35(1), 169-174.
 [http://dx.doi.org/10.1161/01.STR.0000106762.55994.86] [PMID: 14671243]

[120]
Chi, M.S. Editorial commentary vitamin B6 in cholesterol metabolism. Nutr. Res.,  1984, 4(3), 359-362.
 [http://dx.doi.org/10.1016/S0271-5317(84)80096-2]

[121]
Di Napoli, M.; Papa, F.; Bocola, V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke,  2001, 32(4), 917-924.
 [http://dx.doi.org/10.1161/01.STR.32.4.917] [PMID: 11283392]

[122]
Rost, N.S.; Wolf, P.A.; Kase, C.S.; Kelly-Hayes, M.; Silbershatz, H.; Massaro, J.M.; D’Agostino, R.B.; Franzblau, C.; Wilson, P.W.F. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke,  2001, 32(11), 2575-2579.
 [http://dx.doi.org/10.1161/hs1101.098151] [PMID: 11692019]

[123]
Kelly, P.J.; Shih, V.E.; Kistler, J.P.; Barron, M.; Lee, H.; Mandell, R.; Furie, K.L. Low vitamin B6 but not homocyst(e)ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification. Stroke,  2003, 34(6), e51-e54.
 [http://dx.doi.org/10.1161/01.STR.0000071109.23410.AB] [PMID: 12738890]

[124]
Kelly, P.J.; Kistler, J.P.; Shih, V.E.; Mandell, R.; Atassi, N.; Barron, M.; Lee, H.; Silveira, S.; Furie, K.L. Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke,  2004, 35(1), 12-15.
 [http://dx.doi.org/10.1161/01.STR.0000106481.59944.2F] [PMID: 14657454]

[125]
Dusitanond, P.; Eikelboom, J.W.; Hankey, G.J.; Thom, J.; Gilmore, G.; Loh, K.; Yi, Q.; Klijn, C.J.M.; Langton, P.; van Bockxmeer, F.M.; Baker, R.; Jamrozik, K. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial. Stroke,  2005, 36(1), 144-146.
 [http://dx.doi.org/10.1161/01.STR.0000150494.91762.70] [PMID: 15569860]

[126]
Younes-Mhenni, S.; Derex, L.; Berruyer, M.; Nighoghossian, N.; Philippeau, F.; Salzmann, M.; Trouillas, P. Large-artery stroke in a young patient with Crohn’s disease. Role of vitamin B6 deficiency-induced hyperhomocysteinemia. J. Neurol. Sci.,  2004, 221(1-2), 113-115.
 [http://dx.doi.org/10.1016/j.jns.2004.03.016] [PMID: 15178225]

[127]
Till, U.; Röhl, P.; Jentsch, A.; Till, H.; Müller, A.; Bellstedt, K.; Plonné, D.; Fink, H.S.; Vollandt, R.; Sliwka, U.; Herrmann, F.H.; Petermann, H.; Riezler, R. Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, Vitamins B6 and B12. Atherosclerosis,  2005, 181(1), 131-135.
 [http://dx.doi.org/10.1016/j.atherosclerosis.2004.12.043] [PMID: 15939064]

[128]
Macko, R.F.; Kittner, S.J.; Ivey, F.M.; Epstein, A.; Sparks, M.J.; Hebel, J.R.; Johnson, C.C.; Wityk, R.J.; Ueland, P.M.; Refsum, H. Effects of vitamin therapy on plasma total homocysteine, endothelial injury markers, and fibrinolysis in stroke patients. J. Stroke Cerebrovasc. Dis.,  2002, 11(1), 1-8.
 [http://dx.doi.org/10.1053/jscd.2002.123968] [PMID: 17903848]

[129]
VITATOPS Trial Study Group. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: A randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol.,  2010, 9(9), 855-865.
 [http://dx.doi.org/10.1016/S1474-4422(10)70187-3] [PMID: 20688574]

[130]
Qin, X.; Fan, F.; Cui, Y.; Chen, F.; Chen, Y.; Cheng, X.; Li, Y.; Wang, B.; Xu, X.; Xu, X.; Huo, Y.; Wang, X. Folic acid supplementation with and without vitamin B6 and revascularization risk: A meta-analysis of randomized controlled trials. Clin. Nutr.,  2014, 33(4), 603-612.
 [http://dx.doi.org/10.1016/j.clnu.2014.01.006] [PMID: 24461473]

[131]
Wang, X.; Qin, X.; Demirtas, H.; Li, J.; Mao, G.; Huo, Y.; Sun, N.; Liu, L.; Xu, X. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet,  2007, 369(9576), 1876-1882.
 [http://dx.doi.org/10.1016/S0140-6736(07)60854-X] [PMID: 17544768]

[132]
Huo, Y.; Qin, X.; Wang, J.; Sun, N.; Zeng, Q.; Xu, X.; Liu, L.; Xu, X.; Wang, X. Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis. Int. J. Clin. Pract.,  2012, 66(6), 544-551.
 [http://dx.doi.org/10.1111/j.1742-1241.2012.02929.x] [PMID: 22607506]

[133]
Qin, X.; Huo, Y.; Langman, C.B.; Hou, F.; Chen, Y.; Matossian, D.; Xu, X.; Wang, X. Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis. Clin. J. Am. Soc. Nephrol.,  2011, 6(3), 482-488.
 [http://dx.doi.org/10.2215/CJN.05310610] [PMID: 21088292]

[134]
Qin, X.; Huo, Y.; Xie, D.; Hou, F.; Xu, X.; Wang, X. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: A meta-analysis of randomized controlled trials. Clin. Nutr.,  2013, 32(5), 722-727.
 [http://dx.doi.org/10.1016/j.clnu.2012.12.009] [PMID: 23313356]

[135]
Qin, X.; Xu, M.; Zhang, Y.; Li, J.; Xu, X.; Wang, X.; Xu, X.; Huo, Y. Effect of folic acid supplementation on the progression of carotid intima-media thickness: A meta-analysis of randomized controlled trials. Atherosclerosis,  2012, 222(2), 307-313.
 [http://dx.doi.org/10.1016/j.atherosclerosis.2011.12.007] [PMID: 22209480]

[136]
Qin, X.; Cui, Y.; Shen, L.; Sun, N.; Zhang, Y.; Li, J.; Xu, X.; Wang, B.; Xu, X.; Huo, Y.; Wang, X. Folic acid supplementation and cancer risk: A meta-analysis of randomized controlled trials. Int. J. Cancer,  2013, 133(5), 1033-1041.
 [http://dx.doi.org/10.1002/ijc.28038] [PMID: 23338728]

[137]
Keene, K.L.; Chen, W.M.; Chen, F.; Williams, S.R.; Elkhatib, S.D.; Hsu, F.C.; Mychaleckyj, J.C.; Doheny, K.F.; Pugh, E.W.; Ling, H.; Laurie, C.C.; Gogarten, S.M.; Madden, E.B.; Worrall, B.B.; Sale, M.M. Genetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial. Front. Public Health,  2014, 2, 112.
 [http://dx.doi.org/10.3389/fpubh.2014.00112] [PMID: 25147783]

[138]
Spence, J.D.; Howard, V.J.; Chambless, L.E.; Malinow, M.R.; Pettigrew, L.C.; Stampfer, M.; Toole, J.F. Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design. Neuroepidemiology,  2001, 20(1), 16-25.
 [http://dx.doi.org/10.1159/000054753] [PMID: 11174041]

[139]
Toole, J.F. Vitamin intervention for stroke prevention. J. Neurol. Sci.,  2002, 203-204, 121-124.
 [http://dx.doi.org/10.1016/S0022-510X(02)00265-4] [PMID: 12417369]

[140]
Hazra, A.; Kraft, P.; Lazarus, R.; Chen, C.; Chanock, S.J.; Jacques, P.; Selhub, J.; Hunter, D.J. Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum. Mol. Genet.,  2009, 18(23), 4677-4687.
 [http://dx.doi.org/10.1093/hmg/ddp428] [PMID: 19744961]

[141]
Sawuła, W.; Banecka-Majkutewicz, Z.; Kadziński, L.; Jakóbkiewicz-Banecka, J.; Węgrzyn, G.; Nyka, W.; Banecki, B. Homocysteine level and metabolism in ischemic stroke in the population of Northern Poland. Clin. Biochem.,  2009, 42(6), 442-447.
 [http://dx.doi.org/10.1016/j.clinbiochem.2008.12.019] [PMID: 19166826]

[142]
Agnati, L.F.; Genedani, S.; Rasio, G.; Galantucci, M.; Saltini, S.; Filaferro, M.; Franco, R.; Mora, F.; Ferré, S.; Fuxe, K. Studies on homocysteine plasma levels in Alzheimer’s patients. Relevance for neurodegeneration. J. Neural Transm. (Vienna),  2005, 112(1), 163-169.
 [http://dx.doi.org/10.1007/s00702-004-0154-7] [PMID: 15599614]

[143]
Schneiderman, J.H.; Sharpe, J.A.; Sutton, D.M.C. Cerebral and retinal vascular complications of inflammatory bowel disease. Ann. Neurol.,  1979, 5(4), 331-337.
 [http://dx.doi.org/10.1002/ana.410050405] [PMID: 443768]

[144]
Penix, L.P. Ischemic strokes secondary to vitamin B 12 deficiency-induced hyperhomocystinemia. Neurology,  1998, 51(2), 622-624.
 [http://dx.doi.org/10.1212/WNL.51.2.622] [PMID: 9710054]

[145]
Larsson, S.C.; Männistö, S.; Virtanen, M.J.; Kontto, J.; Albanes, D.; Virtamo, J. Folate, vitamin B6, vitamin B12, and methionine intakes and risk of stroke subtypes in male smokers. Am. J. Epidemiol.,  2008, 167(8), 954-961.
 [http://dx.doi.org/10.1093/aje/kwm395] [PMID: 18270369]

[146]
Pietinen, P.; Hartman, A.M.; Haapa, E.; Räsänen, L.; Haapakoski, J.; Palmgren, J.; Albanes, D.; Virtamo, J.; Huttunen, J.K. REPRODUCIBILITY AND VALIDITY OF DIETARY ASSESSMENT INSTRUMENTS. Am. J. Epidemiol.,  1988, 128(3), 655-666.
 [http://dx.doi.org/10.1093/oxfordjournals.aje.a115013] [PMID: 2458036]

[147]
Wald, N.J.; Watt, H.C.; Law, M.R.; Weir, D.G.; McPartlin, J.; Scott, J.M. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch. Intern. Med.,  1998, 158(8), 862-867.
 [http://dx.doi.org/10.1001/archinte.158.8.862] [PMID: 9570171]

[148]
Ganguly, P.; Alam, S.F. Role of homocysteine in the development of cardiovascular disease. Nutr. J.,  2015, 14(1), 6.
 [http://dx.doi.org/10.1186/1475-2891-14-6] [PMID: 25577237]

[149]
Rudreshkumar, K.J.; Majumdar, V.; Nagaraja, D.; Christopher, R. Relevance of plasma levels of free homocysteine and methionine as risk predictors for ischemic stroke in the young. Clin. Nutr.,  2018, 37(5), 1715-1721.
 [http://dx.doi.org/10.1016/j.clnu.2017.07.005] [PMID: 28754404]

[150]
Stipanuk, M.H. Metabolism of sulfur-containing amino acids. Annu. Rev. Nutr.,  1986, 6(1), 179-209.
 [http://dx.doi.org/10.1146/annurev.nu.06.070186.001143] [PMID: 3524616]

[151]
Garcia, G.; Trejos, J.; Restrepo, B.; Landázuri, P. Homocisteína, folato e vitamina B12 em pacientes colombianos portadores de coronariopatia. Arq. Bras. Cardiol.,  2007, 89(2), 79-85.
 [http://dx.doi.org/10.1590/S0066-782X2007001400002] [PMID: 17874011]

[152]
Stamler, J.S.; Osborne, J.A.; Jaraki, O.; Rabbani, L.E.; Mullins, M.; Singel, D.; Loscalzo, J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest.,  1993, 91(1), 308-318.
 [http://dx.doi.org/10.1172/JCI116187] [PMID: 8380812]

[153]
Wrenn, R.W.; Raeuber, C.L.; Herman, L.E.; Walton, W.J.; Rosenquist, T.H. Transforming growth factor-beta: Signal transduction via protein kinase C in cultured embryonic vascular smooth muscle cells. In Vitro Cell. Dev. Biol. Anim.,  1993, 29(1), 73-78.
 [http://dx.doi.org/10.1007/BF02634374] [PMID: 8444747]

[154]
Dalton, M.L.; Gadson, P.F., Jr; Wrenn, R.W.; Rosenquist, T.H. Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells. FASEB J.,  1997, 11(8), 703-711.
 [http://dx.doi.org/10.1096/fasebj.11.8.9240971] [PMID: 9240971]

[155]
Li, W.; Zheng, T.; Wang, J.; Altura, B.T.; Altura, B.M. Extracellular magnesium regulates effects of vitamin B 6, B 12 and folate on homocysteinemia-induced depletion of intracellular free magnesium ions in canine cerebral vascular smooth muscle cells: possible relationship to [Ca2+] i, atherogenesis and stroke. Neurosci. Lett.,  1999, 274(2), 83-86.
 [http://dx.doi.org/10.1016/S0304-3940(99)00683-7] [PMID: 10553943]

[156]
Schwaninger, M.; Ringleb, P.; Winter, R.; Kohl, B.; Fiehn, W.; Rieser, P.A.; Walter-Sack, I. Elevated plasma concentrations of homocysteine in antiepileptic drug treatment. Epilepsia,  1999, 40(3), 345-350.
 [http://dx.doi.org/10.1111/j.1528-1157.1999.tb00716.x] [PMID: 10080517]

[157]
Apeland, T.; Mansoor, M.A.; Pentieva, K.; McNulty, H.; Seljeflot, I.; Strandjord, R.E. The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs. Epilepsy Res.,  2002, 51(3), 237-247.
 [http://dx.doi.org/10.1016/S0920-1211(02)00153-5] [PMID: 12399074]

[158]
McCully, K.S. Homocysteine and the pathogenesis of atherosclerosis. Expert Rev. Clin. Pharmacol.,  2015, 8(2), 211-219.
 [http://dx.doi.org/10.1586/17512433.2015.1010516] [PMID: 25653125]

[159]
Hankey, G.J. B vitamins for stroke prevention. Stroke Vasc. Neurol.,  2018, 3(2), 51-58.
 [http://dx.doi.org/10.1136/svn-2018-000156] [PMID: 30022794]

[160]
Straßburg, A.; Krems, C.; Lührmann, P.M.; Hartmann, B.; Neuhäuser-Berthold, M. Effect of age on plasma homocysteine concentrations in young and elderly subjects considering serum vitamin concentrations and different lifestyle factors. Int. J. Vitam. Nutr. Res.,  2004, 74(2), 129-136.
 [http://dx.doi.org/10.1024/0300-9831.74.2.129] [PMID: 15255449]

[161]
Orzechowska-Pawilojc, A.; Sworczak, K.; Lewczuk, A.; Babinska, A. Homocysteine, folate and cobalamin levels in hypothyroid women before and after treatment. Endocr. J.,  2007, 54(3), 471-476.
 [http://dx.doi.org/10.1507/endocrj.K06-112] [PMID: 17464093]

[162]
Sobczak, A.; Wardas, W.; Zielinska-Danch, W.; Pawlicki, K. The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers. Clinical Chemistry and Laboratory Medicine (CCLM),  2004, 42(4), 408-414.
 [http://dx.doi.org/10.1515/CCLM.2004.072] [PMID: 15147151]

[163]
Spence, J.D.; Urquhart, B.L.; Bang, H. Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine. Nephrol. Dial. Transplant.,  2016, 31(6), 937-944.
 [http://dx.doi.org/10.1093/ndt/gfv380] [PMID: 26567910]

[164]
Kim, J.; Kim, H.; Roh, H.; Kwon, Y. Causes of hyperhomocysteinemia and its pathological significance. Arch. Pharm. Res.,  2018, 41(4), 372-383.
 [http://dx.doi.org/10.1007/s12272-018-1016-4] [PMID: 29552692]

[165]
Fallon, U.B.; Elwood, P.; Ben-Shlomo, Y.; Ubbink, J.B.; Greenwood, R.; Smith, G.D. Homocysteine and ischaemic stroke in men: the Caerphilly study. J. Epidemiol. Community Health,  2001, 55(2), 91-96.
 [http://dx.doi.org/10.1136/jech.55.2.91] [PMID: 11154247]

[166]
Maxwell, C.J.; Hogan, D.B.; Ebly, E.M. Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons. Dement. Geriatr. Cogn. Disord.,  2002, 13(4), 225-234.
 [http://dx.doi.org/10.1159/000057701] [PMID: 12006733]

[167]
Kocer, A.; Ince, N.; Canbulat, E.C.; Sargin, M. Serum vitamin B12 and folic Acid levels in acute cerebral atherothrombotic infarction. Tohoku J. Exp. Med.,  2004, 204(2), 155-161.
 [http://dx.doi.org/10.1620/tjem.204.155] [PMID: 15383696]

[168]
Weikert, C.; Dierkes, J.; Hoffmann, K.; Berger, K.; Drogan, D.; Klipstein-Grobusch, K.; Spranger, J.; Möhlig, M.; Luley, C.; Boeing, H. B vitamin plasma levels and the risk of ischemic stroke and transient ischemic attack in a German cohort. Stroke,  2007, 38(11), 2912-2918.
 [http://dx.doi.org/10.1161/STROKEAHA.107.486068] [PMID: 17885260]

[169]
Wald, D.S.; Wald, N.J.; Morris, J.K.; Law, M. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ,  2006, 333(7578), 1114-1117.
 [http://dx.doi.org/10.1136/bmj.39000.486701.68] [PMID: 17124224]

[170]
Castro, R.; Rivera, I.; Blom, H.J.; Jakobs, C.; de Almeida, I.T. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview. J. Inherit. Metab. Dis.,  2006, 29(1), 3-20.
 [http://dx.doi.org/10.1007/s10545-006-0106-5] [PMID: 16601863]

[171]
Verhoef, P.; Hennekens, C.H.; Malinow, M.R.; Kok, F.J.; Willett, W.C.; Stampfer, M.J. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke,  1994, 25(10), 1924-1930.
 [http://dx.doi.org/10.1161/01.STR.25.10.1924] [PMID: 8091435]

[172]
Alfthan, G.; Pekkanen, J.; Jauhiainen, M.; Pitkäniemi, J.; Karvonen, M.; Tuomilehto, J.; Salonen, J.T.; Ehnholm, C. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis,  1994, 106(1), 9-19.
 [http://dx.doi.org/10.1016/0021-9150(94)90078-7] [PMID: 8018111]

[173]
Perry, I.J.; Morris, R.W.; Ebrahim, S.B.; Shaper, A.G.; Refsum, H.; Ueland, P.M. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet,  1995, 346(8987), 1395-1398.
 [http://dx.doi.org/10.1016/S0140-6736(95)92407-8] [PMID: 7475822]

[174]
Stehouwer, C.D.A.; Weijenberg, M.P.; van den Berg, M.; Jakobs, C.; Feskens, E.J.M.; Kromhout, D. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. Arterioscler. Thromb. Vasc. Biol.,  1998, 18(12), 1895-1901.
 [http://dx.doi.org/10.1161/01.ATV.18.12.1895] [PMID: 9848881]

[175]
Bostom, A.G.; Rosenberg, I.H.; Silbershatz, H.; Jacques, P.F.; Selhub, J.; D’Agostino, R.B.; Wilson, P.W.F.; Wolf, P.A. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann. Intern. Med.,  1999, 131(5), 352-355.
 [http://dx.doi.org/10.7326/0003-4819-131-5-199909070-00006] [PMID: 10475888]

[176]
Aronow, W.S.; Ahn, C.; Gutstein, H. Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons. Am. J. Cardiol.,  2000, 86(5), 585-586, A10.
 [http://dx.doi.org/10.1016/S0002-9149(00)01025-0] [PMID: 11009289]

[177]
Weng, L.C.; Yeh, W.T.; Bai, C.H.; Chen, H.J.; Chuang, S.Y.; Chang, H.Y.; Lin, B.F.; Chen, K.J.; Pan, W.H. Is ischemic stroke risk related to folate status or other nutrients correlated with folate intake? Stroke,  2008, 39(12), 3152-3158.
 [http://dx.doi.org/10.1161/STROKEAHA.108.524934] [PMID: 18988909]

[178]
Honein, M.A.; Paulozzi, L.J.; Mathews, T.J.; Erickson, J.D.; Wong, L.Y. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA,  2001, 285(23), 2981-2986.
 [http://dx.doi.org/10.1001/jama.285.23.2981] [PMID: 11410096]

[179]
De Wals, P.; Tairou, F.; Van Allen, M.I.; Uh, S.H.; Lowry, R.B.; Sibbald, B.; Evans, J.A.; Van den Hof, M.C.; Zimmer, P.; Crowley, M.; Fernandez, B.; Lee, N.S.; Niyonsenga, T. Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med.,  2007, 357(2), 135-142.
 [http://dx.doi.org/10.1056/NEJMoa067103] [PMID: 17625125]

[180]
Giles, W.H.; Kittner, S.J.; Anda, R.F.; Croft, J.B.; Casper, M.L. Serum folate and risk for ischemic stroke. First National Health and Nutrition Examination Survey epidemiologic follow-up study. Stroke,  1995, 26(7), 1166-1170.
 [http://dx.doi.org/10.1161/01.STR.26.7.1166] [PMID: 7604408]

[181]
Sato, Y.; Kaji, M.; Kondo, I.; Yoshida, H.; Satoh, K.; Metoki, N. RETRACTED: Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: Effect of combined therapy with folic acid and mecobalamine. J. Neurol. Sci.,  2002, 202(1-2), 65-68.
 [http://dx.doi.org/10.1016/S0022-510X(02)00210-1] [PMID: 12220694]

[182]
de Bree, A.; Verschuren, W.M.M.; Blom, H.J.; Nadeau, M.; Trijbels, F.J.M.; Kromhout, D. Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study. Atherosclerosis,  2003, 166(2), 369-377.
 [http://dx.doi.org/10.1016/S0021-9150(02)00373-8] [PMID: 12535751]

[183]
Huang, X.; Li, Y.; Li, P.; Li, J.; Bao, H.; Zhang, Y.; Wang, B.; Sun, N.; Wang, J.; He, M.; Yin, D.; Tang, G.; Chen, Y.; Cui, Y.; Huang, Y.; Hou, F.F.; Qin, X.; Huo, Y.; Cheng, X. Association between percent decline in serum total homocysteine and risk of first stroke. Neurology,  2017, 89(20), 2101-2107.
 [http://dx.doi.org/10.1212/WNL.0000000000004648] [PMID: 29030456]

[184]
Spence, J.D.; Yi, Q.; Hankey, G.J. B vitamins in stroke prevention: time to reconsider. Lancet Neurol.,  2017, 16(9), 750-760.
 [http://dx.doi.org/10.1016/S1474-4422(17)30180-1] [PMID: 28816120]

[185]
Bazzano, L.A.; He, J.; Ogden, L.G.; Loria, C.; Vupputuri, S.; Myers, L.; Whelton, P.K. Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey. Stroke,  2002, 33(5), 1183-1189.
 [http://dx.doi.org/10.1161/01.STR.0000014607.90464.88] [PMID: 11988588]

[186]
Van Guelpen, B.; Hultdin, J.; Johansson, I.; Stegmayr, B.; Hallmans, G.; Nilsson, T.K.; Weinehall, L.; Witthöft, C.; Palmqvist, R.; Winkvist, A. Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: a prospective, nested case-referent study of plasma concentrations and dietary intake. Stroke,  2005, 36(7), 1426-1431.
 [http://dx.doi.org/10.1161/01.STR.0000169934.96354.3a] [PMID: 15933256]

[187]
Galan, P.; Kesse-Guyot, E.; Czernichow, S.; Briancon, S.; Blacher, J.; Hercberg, S. Effects of B Vitamins and Omega 3 Fatty Acids on Cardiovascular Diseases: A Randomised Placebo Controlled Trial. BMJ,  2011, 342(7787), 36.
 [http://dx.doi.org/10.1136/bmj.c6273] [PMID: 21115589]

[188]
Holmes, M.V.; Newcombe, P.; Hubacek, J.A.; Sofat, R.; Ricketts, S.L.; Cooper, J.; Breteler, M.M.B.; Bautista, L.E.; Sharma, P.; Whittaker, J.C.; Smeeth, L.; Fowkes, F.G.R.; Algra, A.; Shmeleva, V.; Szolnoki, Z.; Roest, M.; Linnebank, M.; Zacho, J.; Nalls, M.A.; Singleton, A.B.; Ferrucci, L.; Hardy, J.; Worrall, B.B.; Rich, S.S.; Matarin, M.; Norman, P.E.; Flicker, L.; Almeida, O.P.; van Bockxmeer, F.M.; Shimokata, H.; Khaw, K.T.; Wareham, N.J.; Bobak, M.; Sterne, J.A.C.; Smith, G.D.; Talmud, P.J.; van Duijn, C.; Humphries, S.E.; Price, J.F.; Ebrahim, S.; Lawlor, D.A.; Hankey, G.J.; Meschia, J.F.; Sandhu, M.S.; Hingorani, A.D.; Casas, J.P. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet,  2011, 378(9791), 584-594.
 [http://dx.doi.org/10.1016/S0140-6736(11)60872-6] [PMID: 21803414]

[189]
Huo, Y.; Li, J.; Qin, X.; Huang, Y.; Wang, X.; Gottesman, R.F.; Tang, G.; Wang, B.; Chen, D.; He, M.; Fu, J.; Cai, Y.; Shi, X.; Zhang, Y.; Cui, Y.; Sun, N.; Li, X.; Cheng, X.; Wang, J.; Yang, X.; Yang, T.; Xiao, C.; Zhao, G.; Dong, Q.; Zhu, D.; Wang, X.; Ge, J.; Zhao, L.; Hu, D.; Liu, L.; Hou, F.F. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: The CSPPT randomized clinical trial. JAMA,  2015, 313(13), 1325-1335.
 [http://dx.doi.org/10.1001/jama.2015.2274] [PMID: 25771069]

[190]
Kong, X.; Huang, X.; Zhao, M.; Xu, B.; Xu, R.; Song, Y.; Yu, Y.; Yang, W.; Zhang, J.; Liu, L.; Zhang, Y.; Tang, G.; Wang, B.; Hou, F.F.; Li, P.; Cheng, X.; Zhao, S.; Wang, X.; Qin, X.; Li, J.; Huo, Y. Platelet Count Affects Efficacy of Folic Acid in Preventing First Stroke. J. Am. Coll. Cardiol.,  2018, 71(19), 2136-2146.
 [http://dx.doi.org/10.1016/j.jacc.2018.02.072] [PMID: 29747834]

[191]
Zhao, M.; Wu, G.; Li, Y.; Wang, X.; Hou, F.F.; Xu, X.; Qin, X.; Cai, Y. Meta-analysis of folic acid efficacy trials in stroke prevention. Neurology,  2017, 88(19), 1830-1838.
 [http://dx.doi.org/10.1212/WNL.0000000000003909] [PMID: 28404799]

[192]
Wang, Z.M.; Zhou, B.; Nie, Z.L.; Gao, W.; Wang, Y.S.; Zhao, H.; Zhu, J.; Yan, J.J.; Yang, Z.J.; Wang, L.S. Folate and risk of coronary heart disease: A meta-analysis of prospective studies. Nutr. Metab. Cardiovasc. Dis.,  2012, 22(10), 890-899.
 [http://dx.doi.org/10.1016/j.numecd.2011.04.011] [PMID: 21924595]

[193]
Zhou, Z.; Li, J.; Yu, Y.; Li, Y.; Zhang, Y.; Liu, L.; Song, Y.; Zhao, M.; Wang, Y.; Tang, G.; He, M.; Xu, X.; Cai, Y.; Dong, Q.; Yin, D.; Huang, X.; Cheng, X.; Wang, B.; Hou, F.F.; Wang, X.; Qin, X.; Huo, Y. Effect of Smoking and Folate Levels on the Efficacy of Folic Acid Therapy in Prevention of Stroke in Hypertensive Men. Stroke,  2018, 49(1), 114-120.
 [http://dx.doi.org/10.1161/STROKEAHA.117.018273] [PMID: 29273594]

[194]
Tian, T.; Yang, K.Q.; Cui, J.G.; Zhou, L.L.; Zhou, X.L. Folic Acid Supplementation for Stroke Prevention in Patients With Cardiovascular Disease. Am. J. Med. Sci.,  2017, 354(4), 379-387.
 [http://dx.doi.org/10.1016/j.amjms.2017.05.020] [PMID: 29078842]

[195]
Li, Y.; Huang, T.; Zheng, Y.; Muka, T.; Troup, J.; Hu, F.B. Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials. J. Am. Heart Assoc.,  2016, 5(8), e003768.
 [http://dx.doi.org/10.1161/JAHA.116.003768] [PMID: 27528407]

[196]
Jung, J.Y.; Lee, H.S.; Kang, D.G.; Kim, N.S.; Cha, M.H.; Bang, O.S.; Ryu, D.H.; Hwang, G.S. 1H-NMR-based metabolomics study of cerebral infarction. Stroke,  2011, 42(5), 1282-1288.
 [http://dx.doi.org/10.1161/STROKEAHA.110.598789] [PMID: 21474802]

[197]
Davis, C.K.; G K, R. Postischemic supplementation of folic acid improves neuronal survival and regeneration in vitro. Nutr. Res.,  2020, 75, 1-14.
 [http://dx.doi.org/10.1016/j.nutres.2019.12.007] [PMID: 31955011]

[198]
Verhaar, M.C.; Stroes, E.; Rabelink, T.J. Folates and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol.,  2002, 22(1), 6-13.
 [http://dx.doi.org/10.1161/hq0102.102190] [PMID: 11788454]

[199]
Kelly, P.J.; Furie, K.L. Management and prevention of stroke associated with elevated homocysteine. Curr. Treat. Options Cardiovasc. Med.,  2002, 4(5), 363-371.
 [http://dx.doi.org/10.1007/s11936-002-0016-2] [PMID: 12194809]

[200]
Moat, S.J.; Lang, D.; McDowell, I.F.W.; Clarke, Z.L.; Madhavan, A.K.; Lewis, M.J.; Goodfellow, J. Folate, homocysteine, endothelial function and cardiovascular disease. J. Nutr. Biochem.,  2004, 15(2), 64-79.
 [http://dx.doi.org/10.1016/j.jnutbio.2003.08.010] [PMID: 14972346]

[201]
Spence, J.D. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol.,  2007, 6(9), 830-838.
 [http://dx.doi.org/10.1016/S1474-4422(07)70219-3] [PMID: 17706567]

[202]
Martí-Carvajal, A.J.; Solà, I.; Lathyris, D. Updated in: Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst. Rev.,  2015, 1(1), CD006612.
 [http://dx.doi.org/10.1002/14651858.CD006612.pub4] [PMID: 25590290]

[203]
Sikorski, Z.E. Fennema's Food Chemistry (Fifth Edition) – Edited by Srinivasan Damodaran and Kirk L. Parkin. J. Food Biochem.,  2018, 42(2)
 [http://dx.doi.org/10.1111/jfbc.12483]

[204]
Gallieni, M.; Rizzo, M.A.; Maggi, S.; Regalia, A.; Molfino, I.; Crepaldi, G.; Fusaro, M. Vitamin K and bone metabolism in the elderly with normal and reduced kidney function. Eur. Geriatr. Med.,  2013, 4(1), 32-38.
 [http://dx.doi.org/10.1016/j.eurger.2012.10.001]

[205]
Stafford, D.W. The vitamin K cycle. J. Thromb. Haemost.,  2005, 3(8), 1873-1878.
 [http://dx.doi.org/10.1111/j.1538-7836.2005.01419.x] [PMID: 16102054]

[206]
Oldenburg, J.; Marinova, M.; Müller-Reible, C.; Watzka, M. The vitamin K cycle. Vitam. Horm.,  2008, 78(07), 35-62.
 [http://dx.doi.org/10.1016/S0083-6729(07)00003-9] [PMID: 18374189]

[207]
Overbey, D.M.; Jones, E.L.; Robinson, T.N. How hemostatic agents interact with the coagulation cascade. AORN J.,  2014, 100(2), 148-159.
 [http://dx.doi.org/10.1016/j.aorn.2013.12.012] [PMID: 25080416]

[208]
Ferland, G. Present Knowledge in Nutrition, Tenth Edition. In: Present Knowledge in Nutrition; Wiley, 2012; pp. 230-247.
 [http://dx.doi.org/10.1002/9781119946045.ch15]

[209]
Ferland, G. The discovery of vitamin K and its clinical applications. Ann. Nutr. Metab.,  2012, 61(3), 213-218.
 [http://dx.doi.org/10.1159/000343108] [PMID: 23183291]

[210]
Griffin, J.H.; Zlokovic, B.V.; Mosnier, L.O. Activated protein C: biased for translation. Blood,  2015, 125(19), 2898-2907.
 [http://dx.doi.org/10.1182/blood-2015-02-355974] [PMID: 25824691]

[211]
Healy, L.D.; Rigg, R.A.; Griffin, J.H.; McCarty, O.J.T. Regulation of immune cell signaling by activated protein C. J. Leukoc. Biol.,  2018, 103(6), 1197-1203.
 [http://dx.doi.org/10.1002/JLB.3MIR0817-338R] [PMID: 29601101]

[212]
Ferland, G. Vitamin K and the nervous system: an overview of its actions. Adv. Nutr.,  2012, 3(2), 204-212.
 [http://dx.doi.org/10.3945/an.111.001784] [PMID: 22516728]

[213]
Ghozlan, M.F.; Mohamed, A.A.E.H.; Eissa, D.S.; Eldawy, H.S. Low Protein Z Level: A Thrombophilic Risk Biomarker for Acute Coronary Syndrome. Indian J. Hematol. Blood Transfus.,  2019, 35(2), 339-346.
 [http://dx.doi.org/10.1007/s12288-018-1002-5] [PMID: 30988573]

[214]
Napolitano, M.; Mariani, G.; Lapecorella, M. Hereditary combined deficiency of the vitamin K-dependent clotting factors. Orphanet J. Rare Dis.,  2010, 5(1), 21.
 [http://dx.doi.org/10.1186/1750-1172-5-21] [PMID: 20630065]

[215]
Bereczky, Z.; Kovács, K.B.; Muszbek, L.; Protein, C.; Protein, S. Protein C and protein S deficiencies: similarities and differences between two brothers playing in the same game. Clin. Chem. Lab. Med.,  2010, 48, S53-S66.
 [http://dx.doi.org/10.1515/CCLM.2010.369] [PMID: 21054189]

[216]
Howard, B.M.; Kornblith, L.Z.; Cheung, C.K.; Kutcher, M.E.; Miyazawa, B.Y.; Vilardi, R.F.; Cohen, M.J. Inducing Acute Traumatic Coagulopathy In Vitro: The Effects of Activated Protein C on Healthy Human Whole Blood. PLoS One,  2016, 11(3), e0150930.
 [http://dx.doi.org/10.1371/journal.pone.0150930] [PMID: 27008408]

[217]
McQuillan, A.M.; Eikelboom, J.W.; Hankey, G.J.; Baker, R.; Thom, J.; Staton, J.; Yi, Q.; Cole, V. Protein Z in ischemic stroke and its etiologic subtypes. Stroke,  2003, 34(10), 2415-2419.
 [http://dx.doi.org/10.1161/01.STR.0000092124.52084.4B] [PMID: 12970515]

[218]
Kobelt, K.; Biasiutti, F.D.; Mattle, H.P.; Lämmle, B.; Wuillemin, W.A. Protein Z in ischaemic stroke. Br. J. Haematol.,  2001, 114(1), 169-173.
 [http://dx.doi.org/10.1046/j.1365-2141.2001.02913.x] [PMID: 11472363]

[219]
Wang, J.J.; Shi, K.L.; Li, J.W.; Jiang, L.Q.; Caspi, O.; Fang, F.; Xiao, J.; Jing, H.; Zou, L.P. Risk factors for arterial ischemic and hemorrhagic stroke in childhood. Pediatr. Neurol.,  2009, 40(4), 277-281.
 [http://dx.doi.org/10.1016/j.pediatrneurol.2008.11.002] [PMID: 19302940]

[220]
Aydinli, N.; Tatli, B.; Çalişkan, M.; Özmen, M.; Citak, A.; Unuvar, A.; Baykal, T.; Omeroglu, R.E.; Aydin, K.; Sencer, S.; Sencer, A.; Kırış, T. Stroke in Childhood: Experience in Istanbul, Turkey. J. Trop. Pediatr.,  2006, 52(3), 158-162.
 [http://dx.doi.org/10.1093/tropej/fml016] [PMID: 16636011]

[221]
Janssen, R.; Visser, M.P.J.; Dofferhoff, A.S.M.; Vermeer, C.; Janssens, W.; Walk, J.; Vitamin, K. Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019. Br. J. Nutr.,  2021, 126(2), 191-198.
 [http://dx.doi.org/10.1017/S0007114520003979] [PMID: 33023681]

[222]
Anastasi, E.; Ialongo, C.; Labriola, R.; Ferraguti, G.; Lucarelli, M.; Angeloni, A.; Vitamin, K. Vitamin K deficiency and covid-19. Scand. J. Clin. Lab. Invest.,  2020, 80(7), 525-527.
 [http://dx.doi.org/10.1080/00365513.2020.1805122] [PMID: 32779537]

[223]
Vismara, L.A.; Rogers, S.J.; Ogletree, B.T.; Oren, T.; Mcphilemy, C.; Dillenburger, K.; Hilton, J.C.; Seal, B.C.; Dekker, V.; Nauta, M.H. Havioral. J. Autism Dev. Disord.,  2010, 40(1), 18-41.

[224]
Iba, T.; Levy, J.H. Sepsis-induced Coagulopathy and Disseminated Intravascular Coagulation. Anesthesiology,  2020, 132(5), 1238-1245.
 [http://dx.doi.org/10.1097/ALN.0000000000003122] [PMID: 32044801]

[225]
Crofts, T.S.; Seth, E.C.; Hazra, A.B.; Taga, M.E. Cobamide structure depends on both lower ligand availability and CobT substrate specificity. Chem. Biol.,  2013, 20(10), 1265-1274.
 [http://dx.doi.org/10.1016/j.chembiol.2013.08.006] [PMID: 24055007]

[226]
Yajnik, C.S.; Deshmukh, U.S. Fetal programming: Maternal nutrition and role of one-carbon metabolism. Rev. Endocr. Metab. Disord.,  2012, 13(2), 121-127.
 [http://dx.doi.org/10.1007/s11154-012-9214-8] [PMID: 22415298]

[227]
Pezzini, A.; Del Zotto, E.; Padovani, A. Homocysteine and cerebral ischemia: pathogenic and therapeutical implications. Curr. Med. Chem.,  2007, 14(3), 249-263.
 [http://dx.doi.org/10.2174/092986707779941140] [PMID: 17305530]

[228]
Spence, J.D. Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke. Nutr. Res.,  2016, 36(2), 109-116.
 [http://dx.doi.org/10.1016/j.nutres.2015.10.003] [PMID: 26597770]

[229]
Ahmed, S.; Bogiatzi, C.; Hackam, D.G.; Rutledge, A.C.; Sposato, L.A.; Khaw, A.; Mandzia, J.; Azarpazhoo, M.R.; Hachinski, V.; Spence, J.D. Vitamin B 12 deficiency and hyperhomocysteinaemia in outpatients with stroke or transient ischaemic attack: a cohort study at an academic medical centre. BMJ Open,  2019, 9(1), e026564.
 [http://dx.doi.org/10.1136/bmjopen-2018-026564] [PMID: 30670531]

[230]
Kalita, J.; Kumar, G.; Bansal, V.; Misra, U.K. Relationship of homocysteine with other risk factors and outcome of ischemic stroke. Clin. Neurol. Neurosurg.,  2009, 111(4), 364-367.
 [http://dx.doi.org/10.1016/j.clineuro.2008.12.010] [PMID: 19185985]

[231]
Gille, D.; Schmid, A. Vitamin B12 in meat and dairy products. Nutr. Rev.,  2015, 73(2), 106-115.
 [http://dx.doi.org/10.1093/nutrit/nuu011] [PMID: 26024497]

[232]
Rajan, S.; Wallace, J.I.; Beresford, S.A.A.; Brodkin, K.I.; Allen, R.A.; Stabler, S.P. Screening for cobalamin deficiency in geriatric outpatients: prevalence and influence of synthetic cobalamin intake. J. Am. Geriatr. Soc.,  2002, 50(4), 624-630.
 [http://dx.doi.org/10.1046/j.1532-5415.2002.50155.x] [PMID: 11982661]

[233]
Matchar, D.B.; McCrory, D.C.; Millington, D.S.; Feussner, J.R. Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency. Am. J. Med. Sci.,  1994, 308(5), 276-283.
 [http://dx.doi.org/10.1097/00000441-199411000-00004] [PMID: 7977446]

[234]
Giles, W.H.; Croft, J.B.; Greenlund, K.J.; Ford, E.S.; Kittner, S.J. Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Stroke,  1998, 29(12), 2473-2477.
 [http://dx.doi.org/10.1161/01.STR.29.12.2473] [PMID: 9836753]

[235]
Impaired, O. F.; Function, M.; Size, I. D.; Metabolite, C.; Gu, H.; Bottiglieri, T.; Jadavji, N. M. Ischemic stroke and dietary vitamin B12 deficiency in old-aged females: Impaired motor function, increased ischemic damage size, and changed metabolite profiles in brain and cecum tissue. Nutrients,  2022, 14(14), 2960.
 [http://dx.doi.org/10.3390/nu14142960.]

[236]
Ueland, P.M.; Refsum, H.; Beresford, S.A.A.; Vollset, S.E. The controversy over homocysteine and cardiovascular risk. Am. J. Clin. Nutr.,  2000, 72(2), 324-332.
 [http://dx.doi.org/10.1093/ajcn/72.2.324] [PMID: 10919921]

[237]
Christen, W.G.; Ajani, U.A.; Glynn, R.J.; Hennekens, C.H. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch. Intern. Med.,  2000, 160(4), 422-434.
 [http://dx.doi.org/10.1001/archinte.160.4.422] [PMID: 10695683]

[238]
Tanne, D.; Haim, M.; Goldbourt, U.; Boyko, V.; Doolman, R.; Adler, Y.; Brunner, D.; Behar, S.; Sela, B.A. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke,  2003, 34(3), 632-636.
 [http://dx.doi.org/10.1161/01.STR.0000060203.58958.35] [PMID: 12624283]

[239]
Rios, M.Y.; Ortega, A.; Domínguez, B.; Déciga, M.; Rosa, V. Glaucacetalin E and galphimidin B from Galphimia glauca and their anxiolytic activity. J. Ethnopharmacol.,  2020, 259(259), 112939.
 [http://dx.doi.org/10.1016/j.jep.2020.112939] [PMID: 32417425]

[240]
Li, Y.; Zheng, J.; Zhu, Y.; Qu, Y.; Suo, R.; Zhu, Y. Neuroprotective effects of methylcobalamin in cerebral ischemia/reperfusion injury through activation of the ERK1/2 signaling pathway. Int. Immunopharmacol.,  2021, 99(May), 108040.
 [http://dx.doi.org/10.1016/j.intimp.2021.108040] [PMID: 34435586]

[241]
Saposnik, G. The role of vitamin B in stroke prevention: a journey from observational studies to clinical trials and critique of the VITAmins TO Prevent Stroke (VITATOPS). Stroke,  2011, 42(3), 838-842.
 [http://dx.doi.org/10.1161/STROKEAHA.110.608356] [PMID: 21273566]

[242]
Tan, N.C.K.; Venketasubramanian, N.; Saw, S.M.; Tjia, H.T.L. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults. Stroke,  2002, 33(8), 1956-1962.
 [http://dx.doi.org/10.1161/01.STR.0000021899.08659.C8] [PMID: 12154245]

[243]
Brattstrom, L.E.; Hardebo, J.E.; Hultberg, B.L. Moderate homocysteinemia-a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke,  1984, 15(6), 1012-1016.
 [http://dx.doi.org/10.1161/01.STR.15.6.1012] [PMID: 6506111]

[244]
Furie, K.L.; Kelly, P.J. Homocyst(e)ine and stroke. Semin Neurol,  2006, 26(1), 24-32.
 [http://dx.doi.org/10.1055/s-2006-933306.]

[245]
Lalouschek, W.; Aull, S.; Korninger, L.; Mannhalter, C.; Pabinger-Fasching, I.; Schmid, R.W.; Peter Schnider; Zeiler, K. 677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke. J. Neurol. Sci.,  1998, 155(2), 156-162.
 [http://dx.doi.org/10.1016/S0022-510X(97)00311-0] [PMID: 9562260]

[246]
Lalouschek, W.; Aull, S.; Serles, W.; Schnider, P.; Mannhalter, C.; Lang, T.; Deecke, L.; Zeiler, K. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects. J. Lab. Clin. Med.,  1999, 133(6), 575-582.
 [http://dx.doi.org/10.1016/S0022-2143(99)90187-7] [PMID: 10360632]

[247]
Ay, H.; Arsava, E.M.; Tokgözoğlu, S.L.; Özer, N.; Sarıbaş, O. Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation. Stroke,  2003, 34(4), 909-912.
 [http://dx.doi.org/10.1161/01.STR.0000060202.63475.BA] [PMID: 12624219]

[248]
Beccia, M.; Mele, M.C.; Ferrari, M.; Ranieri, M.; Barini, A.; Rasura, M. Young stroke and basal plasma and post-methionine load homocysteine and cysteine levels 1 year after the acute event: do plasma folates make the difference? Eur. J. Neurol.,  2004, 11(4), 269-275.
 [http://dx.doi.org/10.1046/j.1468-1331.2003.00774.x] [PMID: 15061829]

[249]
Karakurum Goksel, B.; Karatas, M.; Nebioglu, A.; Sezgin, N.; Tan, M.; Seydaoglu, G.; Benli, S.; Karaca, S.; Arlier, Z.; Yerdelen, D. Subclinical hypothyroidism, hyperhomocysteinemia and dyslipidemia: investigating links with ischemic stroke in Turkish patients. Neurol. Res.,  2007, 29(8), 871-876.
 [http://dx.doi.org/10.1179/016164107X181833] [PMID: 17588311]

[250]
Moghaddasi, M.; Mamarabadi, M.; Mirzadeh, S.; Freydoonnejad, A.A.; Razjouyan, H. Homocysteine, vitamin B12 and folate levels in Iranian patients with ischemic stroke. Neurol. Res.,  2010, 32(9), 953-956.
 [http://dx.doi.org/10.1179/016164110X12644252260475] [PMID: 20433777]

[251]
Bayır, A.; Ak, A.; Özdinç, Ş.; Seydanoğlu, A.; Köstekçi, Ş.K.; Kara, F. Acute-phase vitamin B12 and folic acid levels in patients with ischemic and hemorrhagic stroke: is there a relationship with prognosis? Neurol. Res.,  2010, 32(2), 115-118.
 [http://dx.doi.org/10.1179/016164109X12445616596201] [PMID: 19825273]

[252]
Omrani, H.Q.; Shandiz, E.E.; Qabai, M.; Chaman, R.; Fard, H.A.; Qaffarpoor, M. Hyperhomocysteinemia, folateo and B12 vitamin in Iranian patients with acute ischemic stroke. ARYA Atheroscler.,  2011, 7(3), 97-101.
 [PMID: 22577454]

[253]
Hariri, M.; Darvishi, L.; Maghsoudi, Z.; Khorvash, F.; Aghaei, M.; Iraj, B.; Ghiasvand, R.; Askari, G. Intakes of Vegetables and Fruits are Negatively Correlated with Risk of Stroke in Iran. Int. J. Prev. Med.,  2013, 4, S300-S305.
 [PMID: 23776742]

[254]
Ashjazadeh, N.; Fathi, M.; Shariat, A. Evaluation of Homocysteine Level as a Risk Factor among Patients with Ischemic Stroke and Its Subtypes. Iran. J. Med. Sci.,  2013, 38(3), 233-239.
 [PMID: 24174694]

[255]
Choe, H.; Hwang, J.Y.; Yun, J.A.; Kim, J.M.; Song, T.J.; Chang, N.; Kim, Y.J.; Kim, Y. Intake of antioxidants and B vitamins is inversely associated with ischemic stroke and cerebral atherosclerosis. Nutr. Res. Pract.,  2016, 10(5), 516-523.
 [http://dx.doi.org/10.4162/nrp.2016.10.5.516] [PMID: 27698959]

[256]
Larsson, S.C.; Traylor, M.; Markus, H.S. Homocysteine and small vessel stroke: A mendelian randomization analysis. Ann. Neurol.,  2019, 85(4), 495-501.
 [http://dx.doi.org/10.1002/ana.25440] [PMID: 30785218]

[257]
Rawashdeh, S.I.; Al-Mistarehi, A.H.; Yassin, A.; Rabab’ah, W.; Skaff, H.; Ibdah, R. A Concurrent Ischemic Stroke, Myocardial Infarction, and Aortic Thrombi in a Young Patient with Hyperhomocysteinemia: A Case Report. Int. Med. Case Rep. J.,  2020, 13, 581-590.
 [http://dx.doi.org/10.2147/IMCRJ.S279603] [PMID: 33192104]

[258]
Qin, X.; Spence, J.D.; Li, J.; Zhang, Y.; Li, Y.; Sun, N.; Liang, M.; Song, Y.; Zhang, Y.; Wang, B.; Cheng, X.; Zhao, L.; Wang, X.; Xu, X.; Huo, Y. Interaction of serum vitamin B 12 and folate with MTHFR genotypes on risk of ischemic stroke. Neurology,  2020, 94(11), e1126-e1136.
 [http://dx.doi.org/10.1212/WNL.0000000000008932] [PMID: 31932513]

[259]
Chiu, T.H.T.; Chang, H.R.; Wang, L.Y.; Chang, C.C.; Lin, M.N.; Lin, C.L. Vegetarian diet and incidence of total, ischemic, and hemorrhagic stroke in 2 cohorts in Taiwan. Neurology,  2020, 94(11), e1112-e1121.
 [http://dx.doi.org/10.1212/WNL.0000000000009093] [PMID: 32102976]

[260]
Kweon, O.J.; Lim, Y.K.; Lee, M.K.; Kim, H.R. Clinical Utility of Serum Holotranscobalamin Measurements in Patients with First-Ever Ischemic Stroke. Dis. Markers,  2021, 2021, 1-10.
 [http://dx.doi.org/10.1155/2021/9914298] [PMID: 34545295]

[261]
Yuan, M.; Wang, B.; Tan, S. Mecobalamin and early functional outcomes of ischemic stroke patients with H-type hypertension. Rev. Assoc. Med. Bras.,  2018, 64(5), 428-432.
 [http://dx.doi.org/10.1590/1806-9282.64.05.428] [PMID: 30304141]

[262]
van Overbeek, E.C.; Staals, J.; van Oostenbrugge, R.J. Vitamin B12 and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patients. PLoS One,  2013, 8(10), e78100.
 [http://dx.doi.org/10.1371/journal.pone.0078100] [PMID: 24155983]

[263]
Huijts, M.; Duits, A.; Staals, J.; van Oostenbrugge, R.J. Association of vitamin B12 deficiency with fatigue and depression after lacunar stroke. PLoS One,  2012, 7(1), e30519.
 [http://dx.doi.org/10.1371/journal.pone.0030519] [PMID: 22276208]

[264]
Keat Wei, L.; Sutherland, H.; Au, A.; Camilleri, E.; Haupt, L.M.; Gan, S.H.; Griffiths, L.R. A potential epigenetic marker mediating serum folate and vitamin B12 levels contributes to the risk of ischemic stroke. BioMed Res. Int.,  2015, 2015, 1-4.
 [http://dx.doi.org/10.1155/2015/167976] [PMID: 25705649]

[265]
Kara, N.; Senes, M.; Coskun, O.; Inan, L.; Saydam, G.; Yucel, D. Urinary methylmalonic acid levels in patients with acute ischemic stroke. Clin. Biochem.,  2009, 42(7-8), 578-583.
 [http://dx.doi.org/10.1016/j.clinbiochem.2009.02.018] [PMID: 19269282]

[266]
Roth, W.; Mohamadzadeh, M. Vitamin B12 and gut-brain homeostasis in the pathophysiology of ischemic stroke. EBioMedicine,  2021, 73, 103676.
 [http://dx.doi.org/10.1016/j.ebiom.2021.103676] [PMID: 34749301]

[267]
Serefhanoglu, S.; Aydogdu, I.; Kekilli, E.; Ilhan, A.; Kuku, I. Measuring holotranscobalamin II, an early indicator of negative vitamin B12 balance, by radioimmunoassay in patients with ischemic cerebrovascular disease. Ann. Hematol.,  2008, 87(5), 391-395.
 [http://dx.doi.org/10.1007/s00277-007-0406-3] [PMID: 17992530]

[268]
Maruotti, N.; Cantatore, F.P. Vitamin D and the immune system. J. Rheumatol.,  2010, 37(3), 491-495.
 [http://dx.doi.org/10.3899/jrheum.090797] [PMID: 20080911]

[269]
Wacker, M.; Holick, M.F. Sunlight and Vitamin D - A global perspective for health. Dermatoendocrinol,  2013, 5(1), 211-217.
 [PMID: 24494057]

[270]
Siotto, M.; Santoro, M.; Aprile, I. Vitamin D and Rehabilitation after Stroke: Status of Art. Appl. Sci. (Basel),  2020, 10(6), 1973.
 [http://dx.doi.org/10.3390/app10061973]

[271]
Bikle, D.D.; Vitamin, D. Vitamin D metabolism, mechanism of action, and clinical applications. Chem. Biol.,  2014, 21(3), 319-329.
 [http://dx.doi.org/10.1016/j.chembiol.2013.12.016] [PMID: 24529992]

[272]
Meyer, V.; Saccone, D.S.; Tugizimana, F.; Asani, F.F.; Jeffery, T.J.; Bornman, L. Methylation of the Vitamin D Receptor (VDR) Gene, Together with Genetic Variation, Race, and Environment Influence the Signaling Efficacy of the Toll-Like Receptor 2/1-VDR Pathway. Front. Immunol.,  2017, 8(SEP), 1048.
 [http://dx.doi.org/10.3389/fimmu.2017.01048] [PMID: 28959253]

[273]
Schneider, M.A. The Importance of Educating Patients With Stroke About Vitamin D. J. Neurosci. Nurs.,  2017, 49(6), 387-389.
 [http://dx.doi.org/10.1097/JNN.0000000000000326] [PMID: 29117036]

[274]
Thapa, L.; Pokhrel, B.; Shrestha, A.; Pradhan, M.; Bhandari, T.R.; Shrestha, S.; Poudel, R.S.; Poudel, R. Status of Vitamin D and its Association with Stroke Risk Factors in Patients with Acute Ischemic Stroke in a Tertiary Care Hospital. JNMA J. Nepal Med. Assoc.,  1970, 52(195), 935-939.
 [http://dx.doi.org/10.31729/jnma.2719] [PMID: 26982669]

[275]
Marek, K.; Cichoń, N.; Saluk-Bijak, J.; Bijak, M.; Miller, E. The Role of Vitamin D in Stroke Prevention and the Effects of Its Supplementation for Post-Stroke Rehabilitation: A Narrative Review. Nutrients,  2022, 14(13), 2761.
 [http://dx.doi.org/10.3390/nu14132761] [PMID: 35807941]

[276]
Prabhakar, S.; Gupta, A.; Modi, M.; Bhadada, S.; Lal, V.; Khurana, D.; Vitamin, D. Vitamin D status and risk of ischemic stroke in North Indian patients. Indian J. Endocrinol. Metab.,  2014, 18(5), 721-725.
 [http://dx.doi.org/10.4103/2230-8210.139241] [PMID: 25285293]

[277]
Zhou, R.; Wang, M.; Huang, H.; Li, W.; Hu, Y.; Wu, T. Lower Vitamin D Status Is Associated with an Increased Risk of Ischemic Stroke: A Systematic Review and Meta-Analysis. Nutrients,  2018, 10(3), 277.
 [http://dx.doi.org/10.3390/nu10030277] [PMID: 29495586]

[278]
Poole, K.E.S.; Loveridge, N.; Barker, P.J.; Halsall, D.J.; Rose, C.; Reeve, J.; Warburton, E.A. Reduced vitamin D in acute stroke. Stroke,  2006, 37(1), 243-245.
 [http://dx.doi.org/10.1161/01.STR.0000195184.24297.c1] [PMID: 16322500]

[279]
Momosaki, R..; Abo, M.; Urashima, M. Vitamin D supplementation and post-stroke rehabilitation: A randomized, double-blind, placebo-controlled trial. Nutrients,  2019, 11(6), 1295.
 [http://dx.doi.org/10.3390/nu11061295.]

[280]
Park, J.Y.; Kim, J.H.; Sim, Y.J.; Jeong, H.J.; Lee, J.H.; Kim, G.C. The association between the serum vitamin D levels and the stroke lesion size, functional ability, and cognition in elderly Korean ischemic stroke patients. Medicine (Baltimore),  2022, 101(35), e04086.
 [http://dx.doi.org/10.1097/MD.0000000000030402] [PMID: 36107604]

[281]
Miao, H.; Zhu, H.; Luan, X.; Huang, G.; Chen, M.; Yuan, Z.; Wang, Z. Risk Factors of Vitamin D Deficiency in Chinese Ischemic Stroke Patients: A Cross-Sectional Study. Front. Aging Neurosci.,  2021, 12(January), 613498.
 [http://dx.doi.org/10.3389/fnagi.2020.613498] [PMID: 33536895]

[282]
Libien, J.; Kupersmith, M.J.; Blaner, W.; McDermott, M.P.; Gao, S.; Liu, Y.; Corbett, J.; Wall, M. Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial. J. Neurol. Sci.,  2017, 372, 78-84.
 [http://dx.doi.org/10.1016/j.jns.2016.11.014] [PMID: 28017254]

[283]
Conaway, H.H.; Henning, P.; Lerner, U.H. Vitamin a metabolism, action, and role in skeletal homeostasis. Endocr. Rev.,  2013, 34(6), 766-797.
 [http://dx.doi.org/10.1210/er.2012-1071] [PMID: 23720297]

[284]
D’Ambrosio, D.N.; Clugston, R.D.; Blaner, W.S.; Vitamin, A. Vitamin A metabolism: an update. Nutrients,  2011, 3(1), 63-103.
 [http://dx.doi.org/10.3390/nu3010063] [PMID: 21350678]

[285]
Min, K.B.; Min, J.Y. Relation of serum vitamin A levels to all- cause and cause-specific mortality among older adults in the NHANES III population. Nutr. Metab. Cardiovasc. Dis.,  2014, 24(11), 1197-1203.
 [http://dx.doi.org/10.1016/j.numecd.2014.06.004] [PMID: 25149896]

[286]
Sato, Y.; Meller, R.; Yang, T.; Taki, W.; Simon, R.P. Stereo-selective neuroprotection against stroke with vitamin A derivatives. Brain Res.,  2008, 1241, 188-192.
 [http://dx.doi.org/10.1016/j.brainres.2008.09.020] [PMID: 18824156]

[287]
Rist, P.M.; Jiménez, M.C.; Tworoger, S.S.; Hu, F.B.; Manson, J.E.; Sun, Q.; Rexrode, K.M. Plasma Retinol-Binding Protein 4 Levels and the Risk of Ischemic Stroke among Women. J. Stroke Cerebrovasc. Dis.,  2018, 27(1), 68-75.
 [http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2017.08.003] [PMID: 28888344]

[288]
Cichon, N.; Saluk-Bijak, J.; Miller, E.; Gorniak, L.; Redlicka, J.; Niwald, M.; Bijak, M. The Role of Supplementation with Natural Compounds in Post-Stroke Patients. Int. J. Mol. Sci.,  2021, 22(15), 7893.
 [http://dx.doi.org/10.3390/ijms22157893] [PMID: 34360658]

[289]
Kadri, A.; Sjahrir, H.; Juwita Sembiring, R.; Ichwan, M. Combination of vitamin A and D supplementation for ischemic stroke: effects on interleukin-1ß and clinical outcome. Med. Glas.,  2020, 17(2), 425-432.
 [http://dx.doi.org/10.17392/1137-20] [PMID: 32567290]

[290]
Sultana, A.; Rahman, K.; Heyat, M.B.B.; Akhtar, F.; Muaad, AY.; ., Sumbul. Role of inflammation, oxidative stress, and mitochondrial changes in premenstrual psychosomatic behavioral symptoms with anti-inflammatory, antioxidant herbs, and nutritional supplements. Oxid Med Cell Longev.,  2022, 2022, 3599246.
 [http://dx.doi.org/10.1155/2022/3599246.]

[291]
da Silva, G.B.; Yamauchi, M.A.; Bagatini, M.D. Oxidative Stress in Hashimoto’s Thyroiditis: Possible Adjuvant Therapies to Attenuate Deleterious Effects. Mol. Cell. Biochem.,  2022, 1-18.
 [PMID: 36168075]

[292]
Herranz-López, M.; Olivares-Vicente, M.; Encinar, J.; Barrajón- Catalán, E.; Segura-Carretero, A.; Joven, J.; Micol, V. Multi-Targeted Molecular Effects of Hibiscus sabdariffa Polyphenols: An Opportunity for a Global Approach to Obesity. Nutrients,  2017, 9(8), 907.
 [http://dx.doi.org/10.3390/nu9080907] [PMID: 28825642]

[293]
Shen, M.; Zheng, Y.; Li, G.; Chen, Y.; Huang, L.; Wu, J.; Hong, C. Dual Antioxidant DH-217 Mitigated Cerebral Ischemia–Reperfusion Injury by Targeting IKKβ/Nrf2/HO-1 Signal Axis. Neurochem. Res.,  2022, 1-12.

[294]
Brouwer, I.A.; van Dusseldorp, M.; West, C.E.; Meyboom, S.; Thomas, C.M.G.; Duran, M.; van het Hof, K.H.; Eskes, T.K.A.B.; Hautvast, J.G.A.J.; Steegers-Theunissen, R.P.M. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J. Nutr.,  1999, 129(6), 1135-1139.
 [http://dx.doi.org/10.1093/jn/129.6.1135] [PMID: 10356077]

[295]
Homocysteine Lowering Trialists’ Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am. J. Clin. Nutr.,  2005, 82(4), 806-812.
 [http://dx.doi.org/10.1093/ajcn/82.4.806] [PMID: 16210710]

[296]
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease. Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease. N. Engl. J. Med.,  2006, 354(15), 1567-1577.
 [http://dx.doi.org/10.1056/NEJMoa060900] [PMID: 16531613]

[297]
Kennedy, D. B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review. Nutrients,  2016, 8(2), 68.
 [http://dx.doi.org/10.3390/nu8020068] [PMID: 26828517]
Cite As
Current Topics in Medicinal Chemistry

The Multitarget Action of Vitamins in the Ischemic Stroke

Abstract

Graphical Abstract
